UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM  _________ to __________

 

COMMISSION FILE NUMBER 001-41977

 

NATURE’S MIRACLE HOLDING INC.

(Exact name of registrant as specified in its charter)

 

Delaware   88-3986430

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

858 N. Central Ave.

Upland, CA 91786

 

 

(949) 798-6260

(Address of principal executive offices) (Zip Code)   (Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   NMHI   The Nasdaq Stock Market LLC
         
Warrants to purchase Common Stock, at an exercise price of $11.50 per share   NMHIW   The Nasdaq Stock Market LLC

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒ No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒ No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes  ☐ No  

 

As of November 14, 2024, the registrant had a total of 58,470,395  shares of its common stock, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

 

INDEX

 

  Page
PART I. FINANCIAL INFORMATION 1
Item 1. Consolidated Condensed Financial Statements (unaudited) 1
  Consolidated Condensed Balance Sheets 1
  Consolidated Condensed Statements of Operations and Comprehensive Loss 2
  Consolidated Condensed Statements of Stockholders’ Equity 3
  Consolidated Condensed Statements of Cash Flows 4
  Notes to Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 3. Quantitative and Qualitative Disclosures About Market Risk 45
Item 4. Controls and Procedures 45
PART II. OTHER INFORMATION 46
Item 1. Legal Proceedings 46
Item 1A. Risk Factors 46
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46
Item 3. Defaults Upon Senior Securities 46
Item 4. Mine Safety Disclosures 46
Item 5. Other Information 46
Item 6. Exhibits 47
SIGNATURES 48

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends impacting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

 

Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expect,” “intend,” “seek,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential,” “might,” “forecast,” “continue,” or the negative of those terms, and similar expressions and comparable terminology intended to reference future periods. Forward-looking statements include, but are not limited to, statements about:

 

  Our ability to effectively operate our business segments;

 

  Our ability to manage our research, development, expansion, growth and operating expenses;

 

  Our ability to evaluate and measure our business, prospects and performance metrics;

 

  Our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry;

 

  Our ability to respond and adapt to changes in technology and customer behavior; and

 

  Our ability to protect our intellectual property and to develop, maintain and enhance a strong brand.

 

Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

 

Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, the forward-looking statements in this Quarterly Report on Form 10-Q should not be regarded as representations that the results or conditions described in such statements will occur or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements.

 

ii

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

   As of
September 30,
   As of
December 31,
 
   2024   2023 
   (Unaudited)     
ASSETS        
CURRENT ASSETS        
Cash and cash equivalent  $40,114   $221,760 
Accounts receivable, net   2,376,603    1,236,248 
Accounts receivable - related parties, net   1,850,601    305,669 
Inventories, net   3,333,539    5,046,084 
Prepayments and other current assets   393,439    139,734 
Loans receivable - related parties   
-
    460,000 
Total Current Assets   7,994,296    7,409,495 
           
NON-CURRENT ASSETS          
Security deposit   27,633    47,633 
Right-of-use assets, net   582,890    503,089 
Cost method investment   1,000,000    1,000,000 
Property and equipment, net   4,286,692    4,406,272 
Deferred offering costs   
-
    833,932 
Total Assets  $13,891,511   $14,200,421 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Short-term loans  $2,856,673   $509,443 
Short-term loans - related parties   858,255    783,255 
Current portion of long-term debts   293,541    268,805 
Convertible notes   681,410    
-
 
Accounts payable   9,356,293    8,034,044 
Accounts payable - related parties   572,500    2,758,074 
Other payables and accrued liabilities   3,469,680    1,351,951 
Other payables - related parties   348,658    257,954 
Operating lease liabilities - current   451,417    359,459 
Tax accrual   469,419    340,628 
Deferred income - Contract liabilities   312,094    118,909 
Deferred income - Contract liabilities – related party   64,468    
-
 
Total Current Liabilities   19,734,408    14,782,522 
           
NON-CURRENT LIABILITIES          
Long-term debts, net of current portion   5,757,460    5,979,939 
Operating lease liabilities, net of current portion   235,040    157,897 
Total Non-Current Liabilities   5,992,500    6,137,836 
           
Total Liabilities   25,726,908    20,920,358 
           
COMMITMENTS AND CONTINGENCIES   
 
    
 
 
           
SHAREHOLDERS’ DEFICIT          
Preferred Stock ($0.0001 par value, 1,000,000 shares authorized, none issued and outstanding at September 30, 2024 and December 31, 2023, respectively)   
-
    
-
 
Common Stock ($0.0001 par value,100,000,000 shares authorized, 31,636,764 and 22,272,478 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively)*   3,163    2,227 
Additional paid-in capital   5,939,783    1,526,773 
Accumulated deficit   (17,777,200)   (8,247,862)
Accumulated other comprehensive loss   (1,143)   (1,075)
Total Stockholders’ Deficit   (11,835,397)   (6,719,937)
           
Total Liabilities and Stockholders’ Deficit  $13,891,511   $14,200,421 

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

   For the
Three Months
Ended
   For the
Three Months
Ended
   For the
Nine Months
Ended
   For the
Nine Months
Ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
                 
REVENUE (including related party revenue of $1,135,628 and $10,425 for the three months ended September 30, 2024 and 2023; $2,129,726 and $35,522 for the nine months ended September 30, 2024 and 2023)  $3,052,727   $2,690,690   $8,662,414   $7,600,890 
                     
COST OF REVENUE   2,824,614    2,531,922    7,669,764    7,044,591 
                     
GROSS PROFIT   228,113    158,768    992,650    556,299 
                     
OPERATING EXPENSES:                    
Selling, general and administrative   1,375,475    579,827    4,059,595    1,594,873 
Stock compensation expenses   848,075    
-
    1,215,880    
-
 
Total operating expenses   2,223,550    579,827    5,275,475    1,594,873 
                     
LOSS FROM OPERATIONS   (1,995,437)   (421,059)   (4,282,825)   (1,038,574)
                     
OTHER INCOME (EXPENSE)                    
Interest expense, net   (738,468)   (133,047)   (1,527,443)   (493,067)
Non cash finance expense   
-
    
-
    (1,000,000)   
-
 
Loss on loan extinguishment   (15,131)   
-
    (15,131)   (233,450)
Other (expense) income   (1,300)   (5,023)   2,438    1,323 
Total other expense, net   (754,899)   (138,070)   (2,540,136)   (725,194)
                     
LOSS BEFORE INCOME TAXES   (2,750,336)   (559,129)   (6,822,961)   (1,763,768)
                     
PROVISION FOR (BENEFIT OF) INCOME TAXES   -    (155,163)   2,500    (385,853)
                     
NET LOSS  $(2,750,336)  $(403,966)  $(6,825,461)  $(1,377,915)
                     
OTHER COMPREHENSIVE LOSS                    
Foreign currency translation adjustment   (35)   85    (68)   876 
COMPREHENSIVE LOSS  $(2,750,371)  $(403,881)  $(6,825,529)  $(1,377,039)
                     
WEIGHTED AVERAGE NUMBER OF COMMON STOCK*                    
Basic and diluted   30,241,099    22,272,478    26,622,599    22,272,478 
                     
LOSS PER SHARE                    
Basic and diluted  $(0.09)  $(0.02)  $(0.26)  $(0.06)

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN STOCKHOLDERS’ DEFICIT

 

   Preferred stock   Common stock   Additional
paid in
   Accumulated    Accumulated other
comprehensive
     
   Shares   Amount   Shares*   Amount    capital    Deficit    loss    Total  
BALANCE, December 31, 2023              -   $          -    22,272,478   $2,227   $1,526,773   $(8,247,862)  $(1,075)  $(6,719,937)
Issuance of shares upon the reverse recapitalization   -    -    4,034,286    403    -    (2,703,877)   -    (2,703,474)
Stock compensation expense   -    -    62,740    6    171,891    -    -    171,897 
Shares to be issued for stock compensation   -    -    (62,740)   (6)   6    -    -    - 
Foreign currency translation adjustments   -    -    -    -    -    -    50    50 
Net loss   -    -    -    -    -    (2,306,806)   -    (2,306,806)
BALANCE, March 31, 2024 (Unaudited)   -   $-    26,306,764   $2,630   $1,698,670   $(13,258,545)  $(1,025)  $(11,558,270)
Stock compensation expense   -    -    162,465    16    195,892    -    -    195,908 
Shares to be issued for stock compensation   -    -    (12,465)   (1)   1    -    -    - 
Foreign currency translation adjustments   -    -    -    -    -    -    (83)   (83)
Net loss   -    -    -    -    -    (1,768,319)   -    (1,768,319)
BALANCE, June 30, 2024 (Unaudited)   -   $-    26,456,764   $2,645   $1,894,563   $(15,026,864)  $(1,108)  $(13,130,764)
Stock compensation expense   -    -    84,808    8    848,067    -    -    848,075 
Shares to be issued for stock compensation   -    -    (84,808)   (8)   8    -    -    - 
Shares and warrants issued through public offering             5,000,000    500    1,003,500    -    -    1,004,000 
Shares and warrants issued through private placement             180,000    18    58,072         
 
    58,090 
Forgiveness of related party’s debt   -    -    -    -    2,135,573    -    -    2,135,573 
Foreign currency translation adjustments   -    -    -    -    -    -    (35)   (35)
Net loss   -    -    -    -    -    (2,750,336)   -    (2,750,336)
BALANCE, September 30, 2024 (Unaudited)   -    -    31,636,764    3,163    5,939,783    (17,777,200)   (1,143)   (11,835,397)

 

   Preferred stock   Common stock   Additional
paid in
   Accumulated   Accumulated other
comprehensive
     
   Shares   Amount   Shares*   Amount   capital   Deficit   loss   Total 
BALANCE, December 31, 2022            -   $          -    22,272,478   $2,227   $1,526,773   $(909,691)  $(1,863)  $617,446 
Foreign currency translation adjustments   -    -    -    -    -    -    856    856 
Net loss   -    -    -    -    -    (567,379)   -    (567,379)
BALANCE, March 31, 2023 (Unaudited)   -   $-    22,272,478   $2,227   $1,526,773   $(1,477,070)  $(1,007)  $50,923 
Foreign currency translation adjustments   -    -    -    -    -    -    (65)   (65)
Net loss   -    -    -    -    -    (406,570)   -    (406,570)
BALANCE, June 30, 2023 (Unaudited)   -   $-    22,272,478   $2,227   $1,526,773   $(1,883,640)  $(1,072)  $(355,712)
Foreign currency translation adjustments   -    -    -    -    -    -    85    85 
Net loss   -    -    -    -    -    (403,966)   -    (403,966)
BALANCE, September 30, 2023 (Unaudited)   -    -    22,272,478    2,227    1,526,773    (2,287,606)   (987)   (759,593)

 

*Giving retroactive effect to reverse recapitalization effected on March 11, 2024

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

NATURE’S MIRACLE HOLDING INC., SUBSIDIARIES AND VIE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the
Nine Months
Ended
   For the
Nine Months
Ended
 
   September 30,   September 30, 
   2024   2023 
   (Unaudited)   (Unaudited) 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(6,825,461)  $(1,377,915)
Adjustments to reconcile net income to net cash used in          
operating activities:          
Depreciation expense   119,580    125,082 
Allowance for credit losses   60,988    337,955 
Amortization of operating right-of-use asset   264,187    287,534 
Amortization of debt issuance cost   140,170    82,239 
Deferred taxes benefits   
-
    (389,153)
Loss on loan extinguishment   15,131    233,450 
Loss on early termination of right-of-use asset   
-
    33,423 
Loss on disposal of fixed assets   
-
    8,345 
Stock compensation expenses   1,215,880    
-
 
Non cash finance expense   1,000,000    
-
 
Change in operating assets and liabilities:          
Accounts receivable   (2,746,275)   (206,755)
Inventories   1,712,545    2,785,824 
Prepayments and other current assets   (253,705)   37,884 
Security deposit   20,000    19,088 
Accounts payable   1,272,250    (1,887,791)
Other payables and accrued liabilities   569,915    37,332 
Accrued interest payable - related parties   52,520    37,800 
Operating lease liabilities   (174,886)   (344,006)
Tax accrual   128,791    (26,183)
Deferred income - Contract liabilities   257,653    (611,696)
Net cash used in operating activities   (3,170,717)   (817,543)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Proceeds from the reverse recapitalization   1,120,177    
-
 
Payments of transaction costs incurred by Lakeshore   (1,044,980)   
-
 
Repayments of promissory note – related party of Lakeshore   (75,000)   
-
 
Loan to related parties   
-
    (390,000)
Loan to Lakeshore   (40,000)   
-
 
Loan repayment from third parties   
-
    132,913 
Net cash used in investing activities   (39,803)   (257,087)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Shares and warrants issued through public offering   1,004,000    
-
 
Payments of deferred offering costs   (266,925)   (553,929)
Long-term loan borrowing   
-
    3,338,546 
Repayments on long-term loan   (197,743)   (113,977)
Short-term loan borrowing from third parties   2,977,470    4,812 
Repayments on short-term loan from third parties   (1,075,371)   (1,763,814)
Short-term loan borrowing from related parties   
-
    773,255 
Repayments on short-term loan from related parties   (50,000)   (700,000)
Convertible notes borrowing   797,500    
-
 
Repayments on convertible notes   (198,170)     
Borrowings from other payables - related parties   38,184    1,557 
Net cash provided by financing activities   3,028,945    986,450 
           
EFFECT OF FOREIGN EXCHANGE ON CASH   (71)   876 
           
CHANGES IN CASH   (181,646)   (87,304)
           
CASH AND CASH EQUIVALENT, beginning of period   221,760    810,371 
           
CASH AND CASH EQUIVALENT, end of period  $40,114   $723,067 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for income tax  $3,315   $2,600 
Cash paid for interest  $1,006,605   $454,088 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS:          
Right of use assets acquired under new operating leases  $398,788   $46,284 
Long term investment converted from accounts receivable  $
-
   $1,000,000 
Derecognition of early termination of right-of-use asset  $
-
   $144,602 
Derecognition of early termination of operating lease liabilities  $
-
   $152,179 
Reduce of right-of-use asset and operating lease liabilities based on modification  $54,800   $
-
 
Accumulated deficit acquired upon the reverse recapitalization  $1,603,020   $
-
 
Deferred offering cost converted to APIC upon the reverse recapitalization  $1,100,857   $
-
 
Forgiveness of related party’s debt  $2,135,573   $
-
 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

Nature’s Miracle Holding Inc., Subsidiaries and VIE
Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 — Nature of business and organization

 

Nature’s Miracle Holding Inc., which until March 11, 2024 was known as LBBB Merger Corp. (the “Company”, “Nature’s Miracle”) is a company incorporated on August 1, 2022 under Delaware law as a wholly owned subsidiary of the Lakeshore Acquisition II Corp., a Cayman Islands exempted company (“Lakeshore”).

 

On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware (“Reincorporation”). Immediately after the Reincorporation, the Company consummated the merger contemplated by the Merger Agreement between the Company and Nature’s Miracle, Inc., a Delaware corporation (“NMI”), resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of NMI. (“the Merger”).

 

Pursuant to the Merger Agreement, at the effective time of the Merger, each share of NMI common stock issued and outstanding immediately prior to the effective time was canceled and automatically converted into the right to receive the applicable pro rata portion of shares of the Company common stock, the aggregate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indebtedness (as defined in the Merger Agreement) (the “Merger Consideration”).

 

The Merger is considered as a reverse recapitalization in accordance with Accounting Standards Codification (“ASC”) 805-40. Under this method of accounting, Lakeshore will be treated as the “acquired” company for financial reporting purposes. This determination is primarily based on NMI’s stockholders comprise 84.7% of the voting power of the Company, directors appointed by NMI constituting three of the five members of the Company’s board of directors, NMI’s operations prior to the Merger comprising the only ongoing operations of the Company, and NMI’s senior management comprising all of the senior management of the Company.

 

Accordingly, for accounting purposes, the financial statements of the Company will represent a continuation of the financial statements of NMI with the Merger treated as the equivalent of NMI issuing stock for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger will be presented as those of NMI in financial statements of the Company. The consolidation of the Company and its subsidiaries have been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5. All share and per share data has been retroactively restated to reflect the current capital structure of the Company.

 

The Company is a growing agriculture technology company focusing on the greenhouse and cultivation industry and providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America.

 

Reorganization under NMI

 

NMI is a holding company incorporated on March 31, 2022 in Delaware. NMI has no substantial operations other than holding all the outstanding share capital of its subsidiaries. NMI, its subsidiaries and variable interest entity (“VIE”).

 

On June 1, 2022, NMI entered into the Share Exchange Agreements with the stockholders of Visiontech Group, Inc. (“Visiontech”, a California Company), resulting in the stockholders of Visiontech becoming 56.3% stockholders of NMI and NMI becoming the 100% stockholder of Visiontech. 

 

5

 

 

The transaction was accounted as a reverse recapitalization in accordance with ASC 805. The process of identifying the accounting acquirer began with a consideration of the guidance in ASC 810-10 related to determining the existence of a controlling financial interest. The general rule provided by ASC 810-10 is that the party that holds directly or indirectly greater than 50% of the voting shares has a controlling financial interest. As such, NMI is treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the stockholders of Visiontech to have a majority of the voting power of the post-combination company, Zhiyi (Jonathan) Zhang, former president of Visiontech, became the President of NMI, the relative size of Visiontech compared to NMI. Accordingly, for accounting purposes and the combination was treated as the equivalent of Visiontech issuing shares for the net assets of NMI, accompanied by a recapitalization. The net assets of NMI is stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination would be those of Visiontech.

 

On June 1, 2022, NMI also entered into the Share Exchange Agreements with the stockholders of Hydroman, Inc. (“Hydroman”, a California Company) to acquire 100% of Hydroman by issuing 6,844,000 shares of NMI’s common stock to the stockholders of Hydroman. The transaction was accounted for as a business combination according with ASC 805 where NMI (post combination with Visiontech) is both the legal and accounting acquirer.

 

On July 28, 2022, Nature’s Miracle (California), Inc., (“NMCA”), a California corporation wholly owned by NMI was incorporated. NMCA focuses on greenhouse development services and started providing container grow sales in first quarter of 2024.

 

On August 18, 2022, NMI acquired 100% interest of Photon Technology (Canada) Ltd, a Canadian company (“Photon”) for a total consideration of CAD $62,571 that was equivalent to $45,500. The purchase was accounted for as an asset purchase. Wei Yang, stockholder of NMI, was the sole stockholder of Photon prior to the acquisition. Upon completion of the acquisition, NMI has 100% of the equity interest of Photon, and Photon became a wholly-owned subsidiary of NMI. Photon will focus on manufacturing greenhouse and cultivation- related products. There was no material operation as of September 30, 2024.

 

On August 27, 2021, Visiontech and Upland 858 LLC (“Upland”), who share common stockholders with Visiontech, entered into a promissory note agreement. Upland is a special purchase entity set up to purchase and hold a warehouse located in California. Upland promised to pay to Visiontech the sum of $1,574,079, together with simple interest thereon at the rate of 4.9% per annum. All sums of principal and unpaid interest thereon shall be due and payable in full to Visiontech on August 28, 2026. On January 10, 2022, Upland entered into a $3,000,000 commercial loan at a fixed rate of 3.79% with Bank of the West. With the funding from Visiontech and the bank, Upland purchased a warehouse located in California at the price of $4,395,230. On February 1, 2022, Upland leased the warehouse to Visiontech through a single lease agreement. As such, Visiontech is exposed to the variability of the building owned by Upland and Upland is a VIE of Visiontech. Visiontech is the primary beneficiary of Upland since Visiontech has a controlling financial interest in Upland and it has both (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.

 

On August 27, 2022, Upland entered into an assignment and assumption of unsecured promissory note with Zhiyi (Jonathan) Zhang, Vartor Vahe Doudakian and Yang Wei (collectively “Assignees”). Upland transferred to Assignees all of its right, title, duties, liabilities and obligation under the promissory note signed by and among Visiontech and Upland on August 27, 2021 in the original principal amount of $1,574,079. Visiontech also provided the consent to surrender its right to collect from Upland. As the stockholders are de facto agents of Visiontech, Visiontech and its de facto agents continue to bear the risk of losses or the rights to receive benefits from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity(“VIE”) of Visiontech and the financial statements of Upland was consolidated from the date of control and variable interest existed. See Note 4 for details.

 

Note 2 — Going concern

 

In assessing liquidity, the Company monitors and analyzes cash on-hand and operating expenditure commitments. The Company’s liquidity needs are to meet working capital requirements and operating expense obligations. To date, the Company financed its operations primarily through cash flows from operations, debt financing from financial institution and related parties. As of September 30, 2024 and December 31, 2023, the Company had approximately $0.04 million and $0.2 million in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. The Company’s working capital deficit was approximately $11.7 million and $7.4 million as of September 30, 2024 and December 31, 2023.

 

6

 

 

On October 14, 2024, the Company entered into a securities purchase agreement with a certain investor pursuant to which the Company sold to the investor a convertible promissory note in the aggregate principal amount of $101,200 with an original issue discount of $13,200.  

 

On November 7, 2024, the Company entered into an underwriting agreement with D. Boral Capital LLC as the underwriter, relating to a firm commitment underwritten public offering of (i) 25,133,631 units (the “Units”) at a public offering price of $0.1118 per Unit, with each Unit consisting of one share of common stock, par value $0.0001 per share, of the Company (“Common Stock”), one Series A warrant to purchase one share of Common Stock at an exercise price of $0.1118 per share and one Series B warrant to purchase such number of shares of Common Stock as determined on the Reset Date as defined thereunder, at an exercise price of $0.0001 per shares, and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”) at a public offering price of $0.1117 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant (the “Pre-Funded Warrants”) exercisable for one share of Common Stock at an exercise price of $0.0001 per share, one Series A Warrant and one Series B Warrant. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

 

The Company has experienced recurring losses from operations and negative cash flows from operating activities since 2022. In addition, the Company had, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund its expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support the Company’s cost structure. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.

 

If the Company is unable to realize its assets within the normal operating cycle of a twelve (12) month period, the Company may have to consider supplementing its available sources of funds through the following sources:

 

  financial support from the Company’s related parties and stockholders;

 

  other available sources of financing from banks and other financial institutions;

 

  equity financing through capital market.

 

The Company can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to the Company, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on the Company and would materially adversely affect its ability to continue as a going concern.

 

The unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty. 

 

Note 3 — Basis of presentation and summary of significant accounting policies

 

Basis of presentation

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its variable interest entities and have been prepared in accordance with U.S. GAAP and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in consolidation. 

 

7

 

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiaries, which include its wholly owned subsidiaries and VIE over which the Company exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company and its subsidiaries and VIE have been eliminated upon consolidation.

 

Use of estimates and assumptions

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosures of contingent assets and liabilities as of the date of the unaudited financial statements and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents consist of amounts held as cash on hand and bank deposits. 

 

From time to time, the Company may maintain bank balances in interest bearing accounts in excess of the $250,000 currently insured by the Federal Deposit Insurance Corporation for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash. The amount in excess of the FDIC insurance was $0 as of September 30, 2024.

 

Prepayments and other current assets

 

Prepaid expenses and other current assets primarily include prepaid expenses paid to product providers, and other deposits. Management regularly reviews the aging of such balances and changes in payment and realization trends and records allowances when management believes collection or realization of amounts due are at risk. Accounts considered uncollectable are written off against allowances after exhaustive efforts at collection are made. As of September 30, 2024 and December 31, 2023, no allowance for doubtful account was recorded.

 

Accounts receivable, net

 

During the ordinary course of business, the Company extends unsecured credit to its customers. Accounts receivable are stated at the amount the Company expects to collect from customers. Management reviews its accounts receivable balances each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful accounts is recorded in the period in which loss is determined to be probable based on assessment of specific evidence indicating likelihood of collection, historical experience, account balance aging and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased. Starting from January 1, 2023, the Company adopted ASU No.2016-13 “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASC Topic 326”). The Company used a modified retrospective approach, and the adoption does not have an impact on our unaudited condensed consolidated financial statements. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.

 

8

 

 

Inventory

 

Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. The Company values its inventory using the weighted average costing method. The Company’s policy is to include as a part of cost of goods sold any freight incurred to ship the product from its vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered periodic costs and are reflected in cost of revenue. The Company regularly reviews inventory and considers forecasts of future demand, market conditions and product obsolescence.

  

If the estimated realizable value of the inventory is less than cost, the Company makes provisions in order to reduce its carrying value to its estimated market value. The Company also reviews inventory for slow moving inventory and obsolescence and records impairment for obsolescence. During the three and nine months ended September 30, 2024, there was no inventory impairment loss recorded. During the three and nine months ended September 30, 2023, there was no inventory impairment loss recorded.

 

Cost method investment

 

The Company accounts for investments with less than 20% of the voting shares and does not have the ability to exercise significant influence over operating and financial policies of the investee using the cost method. The Company records cost method investment at the historical cost in its unaudited condensed consolidated financial statements and subsequently records any dividends received from the net accumulated earrings of the investee as income. Dividends received in excess of earnings are considered a return of investment and are recorded as reduction in the cost of the investments.

 

Cost method investment is evaluated for impairment when facts or circumstances indicate that the fair value of the long-term investments is less than its carrying value. An impairment is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near-term prospects of the investments; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. No event had occurred and indicated that other-than-temporary impairment existed and therefore during the three and nine months ended September 30, 2024, the Company did not record any impairment charges for its investments. During the three and nine months ended September 30, 2023, the Company did not record any impairment charges for its investments.

 

Security deposits

 

To maintain a stable supply for goods and build a long-term relationship, the Company may pay certain amount of funds to its vendors as security deposits which are recorded as non-current assets on the balance sheet depending on its return date.

 

Property and equipment

 

Property and equipment are stated at historical cost. Depreciation is provided over the estimated useful life of each class of depreciable assets and is computed using the straight-line method over the useful lives of the assets are as follows:

 

   Useful Life
Machinery and equipment  5 years
Computer and peripherals  3 years
Trucks and automobiles  5 years
Buildings  39 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the statements of operations. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized.

 

9

 

 

Deferred offering costs

 

Deferred offering costs consist primarily of expenses paid to attorneys, consultants, underwriters, and etc. related to its merger transaction. The balance has been offset with the proceeds received after the close of the offering.

  

Fair value measurement

 

The Company adopted ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement disclosure requirements for fair value measurements.

 

ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:

 

Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

 

When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.

 

Fair values of financial instruments

 

Financial instruments include cash and cash equivalents, accounts receivable, prepayments, loan receivable, and other current assets, other payable and accrued liabilities, accounts payable — related parties, short term loans and taxes payable. The Company considers the carrying amount of short-term financial instruments to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization. The Company’s long-term debts are measured at amortized cost, no fair value option is elected.

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. 

 

The Company is a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America.  Majority of the Company’s products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, the Company also provides indoor grow containers to its customers.

 

10

 

 

The Company’s contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by the Company including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving customers that entered into rebate programs with utility companies for using LED lighting, payment term ranges from 60 to 120 days.

 

The Company’s performance obligation is to deliver the products to customers. For indoor grow container products, the Company also involved in customization of the products to suit customer’s specific needs. The provision of customization and configuration to meet certain technical specification per US market and delivery of product is considered one performance obligation as the as the services provided are not distinct within the context of the contract whereas the customers can only obtain benefit when the services and products are provided together. 

  

Transaction prices are mostly fixed. In some contracts, when determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The Company had one contract with customer with installment payment terms of up to 16 months. The difference between the contract price and the Company’s cash selling price of the same products are recognized as interest income over the term of the payments. Interest income amounted to $0 and $78,385 during the three and nine months ended September 30, 2023, respectively. This contract was terminated on July 12, 2023.

 

The Company transfers the risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and the Company has no further obligation to provide services related to such product evidenced by customer signing acceptances upon receipt of goods. Return allowances, which reduce product revenue by the Company’s best estimate of expected product returns, are estimated using historical experience.

 

The Company evaluates the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Company ships the products according to shipping terms on the purchase order or sales order. Once delivery is complete, the Company then sends an invoice to the customer according to the quantity and price of shipment.

 

The Company evaluates the indicators of control in accordance with ASU 2016-08: 1) the Company is the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, the Company has its own brand for marketing. For indoor grow containers products, the Company is also involved in the design and technical specification of the products to meet requirement in the US market 2) The Company assumes inventory risk either through storing the products in its own warehouses; or for drop shipments directly from vendors, the Company takes the title from vendors through inspection and acceptance and is responsible for product damage during shipment period prior to acceptance of its customers and is also responsible for product return if the customer is not satisfied with the products. 3) The Company determines the resale price of the products. 4) The Company is the party that directs the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, the Company considers itself the principal of these arrangements and records revenue on a gross basis.

 

The Company’s disaggregate revenue stream by products are summarized below:

 

   For the
Three Months Ended
   For the
Nine Months Ended
 
   September 30,
2024
   September 30,
2023
   September 30,
2024
   September 30,
2023
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
                 
Grow light  $3,052,727   $2,690,690   $8,518,633   $7,600,890 
Indoor grow containers   -    -    143,781    - 
Total revenues  $3,052,727   $2,690,690   $8,662,414   $7,600,890 

 

Prepayments received from customers prior to the delivery of goods to customers or picked up by the customers are recorded as contract liability under the account Deferred income — contract liabilities.

 

11

 

 

Movements of Deferred income — contract liabilities consisted of the following as of the date indicated:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
Beginning balance  $118,909   $808,118 
Prepayments from customers   796,453    1,370,836 
Recognized as revenues   (538,800)   (2,060,045)
Ending balance  $376,562   $118,909 

 

The Company periodically provides incentive offers to its customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers. Current discount offers, when accepted by the Company’s customers, are treated as a reduction to the transaction price of the related transaction.

 

Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded and estimated based on historical returns which were generally immaterial to the Company.

 

Estimated warranty are immaterial because suppliers provide a warranty period of 1-5 years for all products, varying depending on the product type. After customers provide their purchase invoices and serial numbers for the return products, the factories will issue the replacement products. Additionally, the factories will also bear the corresponding shipping costs, making the company’s warranty expenses negligible.

 

Cost of revenue

 

Cost of revenue mainly consist of costs for purchases of products and related storage, warehouse rent, outbound freight, delivery fees and payroll related expenses.

 

Segment reporting

 

The Company follows ASC 280, Segment Reporting. The Company’s chief operating decision maker, the Chief Executive Officer, reviews the results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and hence, the Company has only one reportable segment. The Company does not distinguish between markets or segments for the purpose of internal reporting. The Company’s long-lived assets are all located in California, United States, and substantially all the Company’s revenues are derived from within the USA. Therefore, no geographical segments are presented.

 

Leases

 

The Company follows ASC 842 — Leases (“ASC 842”), which requires lessees to record right-of-use (“ROU”) assets and related lease obligations on the balance sheet, as well as disclose key information regarding leasing arrangements.

 

ROU assets represent our right to use an underlying asset for the lease terms and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

  

12

 

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their perspective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.

   

As a result of the implementation of certain provisions of ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting and disclosure for uncertainty in tax position, as defined, ASC 740 seeks to reduce the diversity in practice associated with certain aspects of the recognition and measurement related to accounting for income taxes. The Company follows the provisions of ASC 740 and has analyzed filing positions in each of the federal and state jurisdictions where the Company is required to file income tax returns, as well as open tax years in such jurisdictions. The Company has identified the U.S. federal jurisdiction, and the states of Delaware, as its “major” tax jurisdictions.

 

The Company believes that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company’s policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.

 

Stock-based compensation

 

The Company accounts for stock-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that stock-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period.

 

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 718 amended by ASU 2018-07. Under FASB ASC Topic 718, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.  

 

Warrants

 

The Company evaluates the public and private warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both public and private warrants are classified in shareholders’ equity.

 

For issued warrants that meet all of the criteria for equity classification and issued with debt instruments, the proceeds from the sale of the debt instruments are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds so allocated to the warrants is accounted for as paid-in capital. The reminder of the proceeds is allocated to the debt instrument portion of the transaction at a discount and amortized over the term of the debt instrument using the effective interest rate method.

 

13

 

 

Convertible notes

 

Upon adoption of ASU 2020-06 on January 1, 2021, the elimination of the beneficial conversion feature (“BCF”) and cash conversion models in ASC 470-20 that requires separate accounting for embedded conversion features in convertible instruments results in the convertible debt instruments being recorded as a single liability (i.e., there is no separation of the conversion feature, and all proceeds are allocated to the convertible debt instruments as a single unit of account). Unless conversion features are derivatives that must be bifurcated from the host contracts in accordance with ASC 815-15 or, in the case of convertible debt, if the instruments are issued with a substantial premium, in the latter case, ASC 470-20-25-13 requires the substantial premium to be attributable to the conversion feature and recorded in additional paid-in capital (APIC).

 

Commitments and Contingencies

 

In the ordinary course of business, the Company is subject to certain contingencies, including legal proceedings and claims arising out of the business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred, and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and specific facts and circumstances of each matter.

  

Loss per share

 

Basic loss per share is computed by dividing net loss attributable to holders of common stock by the weighted average number of common stock outstanding during the year. Diluted loss per share presents the dilutive effect on a per share basis of the potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted loss per share.

  

Recently issued accounting pronouncements

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures.

 

Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.

 

Note 4 — Variable interest entity

 

The Company does not have direct ownership in Upland but has been actively involved in their operations and has the power to direct the activities and significantly impact Upland’s economic performance. The Company also bears the risk of losses from Upland. As such, in accordance with ASC 810, Upland is considered variable interest entity (“VIE”) of the Company and the financial statements of Upland was consolidated from the date of control and variable interest existed.

  

Based on the loan agreement between its creditor and Upland 858 LLC, the loan is a non-recourse debt secured by the assets owned by Upland 858 LLC only and guaranteed by the stockholders of Upland 858 LLC only. Upland 858 LLC’s creditor will have no-recourse to Visiontech which is considered to be the primary beneficiary of the VIE structure but not the legal owner of Upland 858 LLC:

 

Accordingly, the accounts of Upland were consolidated in the accompanying financial statements as VIE of Visiontech from January 2022 when Upland acquired the warehouse in California.

 

14

 

 

The carrying amount of the assets and liabilities are as follows:

 

   As of
September 30,
2024
 
Cash  $4,774 
Prepaid expense   1,800 
Property and equipment, net   4,158,291 
Total assets  $4,164,865 
      
Current portion of long-term debt  $83,122 
Long-term debt, net of current portion   2,709,406 
Accrued expenses   151 
Intercompany payable to Visiontech   1,337,867 
Total liabilities  $4,130,546 

 

The operating results of VIE included in the unaudited condensed consolidated statements of operations are as follows for the period indicated:

 

    For the 
three months
ended
September 30,
2024
    For the
nine months
ended
September 30,
2024
 
Revenue*   $ 83,210     $ 249,631  
Selling, general and administrative     (26,741 )     (109,191 )
Interest expense     (25,384 )     (76,418 )
Income tax     -       (1,700 )
Net income   $ 31,085     $ 62,322  

 

* Upland generated its revenue from leasing the warehouse to Visiontech. Revenue of Upland was fully eliminated on the unaudited condensed consolidated statements of operations.

 

Note 5 — Reverse recapitalization

 

On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware. Immediately after the Reincorporation, the Company consummated the merger between the Company and NMI, resulting in the stockholders of NMI becoming 84.7% stockholders of the Company and the Company becoming the 100% stockholder of Nature’s Miracle. Lakeshore was treated as the “acquired” company for financial reporting purposes. Accordingly, the financial statements of the Company represent the continuation of the financial statements of NMI, with the Merger reflected as the equivalent of NMI issuing ordinary shares for the net assets of Lakeshore, accompanied by a recapitalization. The net assets of Lakeshore were recognized as of the closing date at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are those of NMI. The shares and corresponding capital amounts and all per share data related to NMI outstanding shares prior to the reverse recapitalization have been retroactively adjusted.

 

15

 

 

The following table presents the number of the Company’s common stock issued and outstanding immediately following the reverse recapitalization:

 

   Common
Stock
 
Lakeshore’s shares outstanding prior to reverse recapitalization   2,241,500 
Shares issued to private rights   35,150 
Conversion of the Lakeshore’s public shares and rights   790,097 
Shares issued to service providers   801,539 
Bonus shares issued to investors   166,000 
Conversion of NMI’s shares into the Company’s ordinary shares   22,272,478 
Total shares outstanding   26,306,764 

 

In connection with the reverse recapitalization, the Company has assumed 3,625,750 warrants outstanding, which consisted of 3,450,000 public warrants and 175,750 private warrants. Both of the public warrants and private warrants met the criteria for equity classification. (see Note 13 Equity for details)

  

In connection with the reverse recapitalization, the Company raised approximately $1.1 million of proceeds, presented as cash flows from investing activities, which included the contribution of approximately $15.1 million of funds held in Lakeshore’s trust account, net of approximately $13.9 million paid to redeem 1,246,563 public shares of Lakeshore’s ordinary shares, approximately $1.0 million in transaction costs incurred by Lakeshore, and repayments of a promissory note in the amount of $75,000 issued to Lakeshore’s related party. NMI incurred approximately $1.1 million of transaction costs, which consisted of direct incremental legal and accounting fees in connection with the Merger and were reclassified to additional paid-in capital. The net effect of the above with the net liabilities assumed from Lakeshore of approximately $1.6 million was recorded to the Company’s retained deficit.

  

The following table reconcile the elements of the reverse recapitalization to the unaudited condensed consolidated statements of cash flows and the changes in shareholders’ equity (deficit):

 

   As of
March 11,
2024
 
Funds held in Lakeshore’s trust account  $15,067,702 
Funds held in Lakeshore’s operating cash account   198 
Less:  amount paid to redeem public shares of Lakeshore’s ordinary shares   (13,947,723)
Proceeds from the reverse recapitalization   1,120,177 
Less:  payments of transaction costs incurred by Lakeshore   (1,044,980)
Less:  repayments of promissory note – related party of Lakeshore’   (75,000)
Less:  notes assumed from Lakeshore   (555,000)
Less:  liability assumed from Lakeshore   (1,547,814)
Less:  transaction costs paid by NMI   (1,100,857)
Add:  receivable assumed from Lakeshore   500,000 
Net liabilities assumed from issuance of common stock upon the Merger, balance classified to retained deficit  $(2,703,474)

 

Note 6 — Accounts receivable, net

 

Accounts receivable consisted of the following as of the date indicated:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
Accounts receivable  $3,096,564   $1,906,222 
Less: allowance for credit losses   (719,961)   (669,974)
Subtotal accounts receivable, net   2,376,603    1,236,248 
Accounts receivable - related parties   1,850,601    305,669 
Total accounts receivable, net  $4,227,204   $1,541,917 

 

16

 

 

Provision for credit losses were $36,597 and $60,988 during the three and nine months ended September 30, 2024, respectively.

 

Provision for credit losses were $337,166 and $337,955 during the three and nine months ended September 30, 2023, respectively.

  

Movement of allowance:

 

Movement of allowance for credit losses consisted of the following as of the date indicated:

 

   September 30,
2024
   December 31,
2023
 
Beginning balance  $669,974   $259,690 
Addition   60,988    907,021 
Recovery/write-off   (11,001)   (496,737)
Ending balance  $719,961   $669,974 

 

Note 7 — Loans Receivable

 

In September 2022, Visiontech and CGGP, LLC (“CGGP”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $123,688. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totaled $21,038. For the three and nine months ended September 30, 2023, the Company paid $0 and $62,383, respectively. This loan has been paid off on March 17, 2023.

  

In September 2022, Visiontech and NewCo Vision, LLC (“NewCo”), a customer who purchased industrial light fixtures, entered into three promissory note agreements with terms of six months. The total amount of the notes was $139,840. The notes bear interest thereon at the annual rate of 7% and requires monthly installment payments totaled $23,785. For the three and nine months ended September 30, 2023, the Company paid $0 and $70,530, respectively. This loan has been paid off on March 17, 2023.

 

Note 8 — Cost method investment

 

Cost method investment consist of the following:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
10% Investment of Iluminar  $1,000,000   $1,000,000 
Total  $1,000,000   $1,000,000 

 

On April 11, 2023, one of the Company’s customers, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. As of September 30, 2024, the shares were issued to the Company. No identified event or change in circumstances that would have a significant adverse effect on the value of investment and the Company determined no impairment was deemed necessary as of September 30, 2024.

 

17

 

 

Note 9 — Property and equipment, net

 

Property and equipment, net consist of the following:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
Trucks & Automobiles  $285,099   $285,099 
Machinery & Equipment   67,847    67,847 
Building   3,465,230    3,465,230 
Land   930,000    930,000 
Subtotal   4,748,176    4,748,176 
Less: accumulated depreciation   (461,484)   (341,904)
Total  $4,286,692   $4,406,272 

 

Depreciation expense during the three and nine months ended September 30, 2024 amounted to $39,860 and $119,580, respectively.

 

Depreciation expense during the three and nine months ended September 30, 2023 amounted to $41,694 and $125,082, respectively.

   

Note 10 — Loans payable

 

Short-term loans:

 

Short-term loans consist of three account receivable factoring agreements, one subordinated business loan, three third parties loans as of September 30, 2024.

 

Short-term loans consist of one account receivable factoring agreement and one individual loan as of December 31, 2023.

 

On October 23, 2023, NMI, Visiontech and Hydroman (collectively “Merchants”) entered into a standard merchant cash advance agreement with Factor H. The Company sold $768,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $503,500 was remitted to the Company, after the deduction of the total fees of $26,500. The Company agreed to pay a weekly installment of $22,814.84 for 32 weeks with a final extra payment of $38,500. The effective interest rate of this agreement was 85.36%. For the three and nine months ended September 30, 2024, the Company paid $181,950 and $409,443 principal of the loan.

 

On May 2, 2024, the Merchants entered into another standard merchant cash advance agreement with Factor H. The Company sold $1,240,150 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $807,500 was remitted to the Company, after the deduction of the total fees of $42,500. The Company agreed to pay a weekly installment of $41,000 for 31 weeks. The effective interest rate of this agreement was 93.05%. The Company use this loan to pay off $175,315 previous loan with Factor H that dated on October 23, 2023. For the three and nine months ended September 30, 2024, the Company paid $240,656 and $310,781 principal of the loan.

 

On August 29, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor I. The Company sold $213,000 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $142,500 was remitted to the Company, after the deduction of the total fees of $7,500. The Company agreed to pay a weekly installment of $8,192 for 26 weeks. The effective interest rate of this agreement was 84.22%. For the three and nine months ended September 30, 2024, the Company paid $15,015 and $15,015 principal of the loan.

 

18

 

 

On September 27, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor J. The Company sold $72,500 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $47,470 was remitted to the Company, after the deduction of the total fees of $2,530. The Company agreed to pay a weekly installment of $3,021 for 24 weeks. The effective interest rate of this agreement was 88.98%. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the loan.

 

On September 30, 2024, the Merchants entered into a standard merchant cash advance agreement with Factor K. The Company sold $181,250 of its accounts receivable balances on a recourse basis for credit approved accounts. The net purchase price of $115,955 was remitted to the Company, after the deduction of the total fees of $9,045. The Company agreed to pay a weekly installment of $7,552 for 24 weeks. The effective interest rate of this agreement was 94.36%. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the loan.

 

These receivable purchase agreements were accounted for as secured borrowing under ASC 860 since there is no legal, actual, effective transfer of the receivables to the Factors. Rather, the Factors only have generally claim against the receivable pools not a particular receivable. As of September 30, 2024 and December 31, 2023, outstanding balance amounted to $671,673 and $409,443, respectively.

 

On October 30, 2023, NMI entered into a loan agreement with an independent third party pursuant to which the Company borrowed a principal amount of $100,000 with an annual interest rate of 12% for a term of one year. The loan was extended to April 15, 2025. The loan balance as of September 30, 2024 and December 31, 2023 was $100,000 and $100,000, respectively.

 

On March 7, 2024, the Company’s subsidiary Nature’s Miracles entered into a loan agreement with Peng Zhang, a shareholder of the Company. The amount of the loan is $1,405,000 with 10% interest and is due on March 7, 2025.

 

On February 10, March 28, June 5, June 27, September 22, December 22, 2023 and February 20, 2024, Lakeshore entered into seven promissory notes with RedOne Investment Limited (“Redone”) to which Lakeshore borrowed an aggregate principal amount of $380,000 with zero interest rate. On July 11, 2023, Lakeshore entered into a loan agreement with Deyin Chen (Bill) to which Lakeshore borrowed a principal amount of $125,000 with an annual interest rate of 8%. This loan was extended to March 11, 2024 with interest waived pursuant to a Side Letter to the loan agreements dated December 8, 2023. A payment of $75,000 was made upon close of the Merger on March 11, 2024 and the loan balance was $50,000 after the payment.

 

On March 11, 2024, NMI, Redone and Deyin Chen (Bill) entered into agreement that $50,000 owed to Deyin Chen (Bill) will be assigned to Redone and the Company will assume the outstanding balance of the loan of $430,000, The loan shall bear interest of 8% per annum. $50,000 initially shall be paid by the Company no later than first month anniversary of March 11, 2024, further extended to May 31, 2024 and had been paid on July 29, 2024. Second payment of $150,000 shall be paid by September 11, 2024, further extended to be due upon the completion of a capital raise by the Company on November 7, 2024, and had been paid on November 11, 2024. The last payment of $230,000 shall be paid by December 11, 2024. Interest expenses of approximately $11,537 and $19,132 was accrued during the three and nine months ended September 30, 2024, respectively.

 

On June 6, 2024, the Merchants entered into a subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $288,750, including the administrative agent fee of $13,750. The Company agreed to pay a weekly installment of $15,056 for 28 weeks. The effective interest rate of this agreement was 99.88%. The collateral consists of the Company’s right, title and interest in and to including the Company’s financial assets, goods, accounts, equipment, inventory, contract rights or rights to payment of money. The Company received the net proceeds on June 7, 2024. For the three and nine months ended September 30, 2024, the Company paid $255,808 and $275,000 principal of the loan.

 

On September 25, 2024, the Merchants entered into another subordinated business loan and security agreement with Agile Capital Funding, LLC and Agile Lending, LLC for the principal amount of $315,000, including the administrative agent fee of $15,000. The Company agreed to pay a weekly installment of $16,425 for 28 weeks. The effective interest rate of this agreement was 90.22%. The Company use this loan to pay off $195,806 previous loan with Agile Capital Funding, LLC and Agile Lending, LLC that dated on June 6, 2024. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the loan.

 

19

 

 

The Company also make the following principal payments for the below loans for the period ended September 30, 2023:

 

On August 31, 2022, the Merchants entered into a standard merchant cash advance agreement with Factor A. Merchants sells to Factor A $1,065,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor A remitted the net purchase price of $712,500 to Merchants, after deducting the total fees of $37,500. Merchants agreed to pay a weekly installment of $26,625 for 40 weeks to Factor A until Factor A received the total purchased amount of receipts. The effective interest rate of this agreement was 105.19%. During the three and nine months ended September 30, 2023, the Company paid $0 and $326,233 principal of the loan, respectively.

  

On September 1, 2022, Visiontech entered into a receivables purchase agreement with another Factor B. Visiontech sold to Factor B $458,500 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor B disbursed the net purchase price of $339,465 to Visiontech, after deducting the origination fees of $10,500. Visiontech agreed to pay a weekly installment of $8,817.31 for 52 weeks to Factor B until Factor B received the total purchased amount of receipts. The effective interest rate of this agreement was 55.79%. During the three and nine months ended September 30, 2023, the Company paid $0 and $262,157 principal of the loan, respectively.

 

On October 31, 2022, Hydroman entered into a receivables purchase agreement with Factor C. Hydroman sold to Factor C $675,000 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor C remitted the net purchase price of $485,000 to Hydroman, after the deduction of the origination fees of $15,000. Hydroman agreed to pay a weekly installment of $16,071 for 42 weeks to Factor C until Factor C receive the total purchased amount of receipts. The effective interest rate of this agreement was 106.56%. During the three and nine months ended September 30, 2023, the Company paid $0 and $367,632 principal of the loan, respectively.

 

On October 31, 2022, Visiontech entered into a future receivable sale and purchase agreement with a capital management institution D at a sale price of $100,000, after the deduction of the origination fees of $10,000. According to the agreement, the amount of receivables being sold was $149,000 with 20% purchased percentage and the estimated daily payment amount is $1,490 for 20 weeks. The effective interest rate of this agreement was 85.25%. During the three and nine months ended September 30, 2023, the Company paid $0 and $68,868 principal of the loan, respectively.

 

On November 2, 2022, Hydroman entered into a receivables purchase agreement with Factor E. Hydroman sold to Factor E $374,750 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor E remitted the net purchase price of $225,000 to Hydroman, after the deduction of the total closing costs of $25,000. Hydroman agreed to pay a weekly installment of $15,615 for 24 weeks to Factor E until Factor E receive the total purchased amount of receipts. The effective interest rate of this agreement was 84.67%. During the three and nine months ended September 30, 2023, the Company paid $0 and $188,441 principal of the loan, respectively.

 

On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor F. The Company sold to Factor F $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor F remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor F until Factor F receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. During the three and nine months ended September 30, 2023, the Company paid $0 and $110,977 principal of the loan, respectively.

 

On November 18, 2022, the “Merchants” entered into a standard merchant cash advance agreement with Factor G. The Company sold to Factor G $206,113 of its accounts receivable balances on a recourse basis for credit approved accounts. Factor G remitted the net purchase price of $123,750 to the Company, after the deduction of the total fees of $13,750. The Company agreed to pay a weekly installment of no more than $8,588 for 24 weeks to Factor G until Factor G receive the total purchased amount of receipts. The effective interest rate of this agreement was 89.96%. During the three and nine months ended September 30, 2023, the Company paid $0 and $110,977 principal of the loan, respectively. 

 

20

 

 

On September 21, 2022, Hydroman signed a commercial loan with WebBank for the principal amount of $100,000. This loan requires a weekly installment payment of $2,244.38 for 52 weeks. The effective interest rate of this loan was 31.22%. The Company paid off this loan on June 14, 2023. During the three and nine months ended September 30, 2023, the Company paid $0 and $76,064 principal of the loan, respectively.

 

On September 18, 2022, Hydroman and ClassicPlan Premium Financing, Inc., entered into a premium financing agreement with a total gross policy premium and related fees of $35,508 and financed $26,387 of it. Hydroman needs to pay a monthly installment of $3,065 for six months with the last installment due on May 19, 2023. The effective interest rate of this loan was 10.80%. The Company paid off this loan on May 16, 2023. During the three and nine months ended September 30, 2023, the Company paid $0 and $14,922 principal of the loan, respectively.

 

On February 13, 2023, Hydroman and First Insurance Funding entered into a premium financing agreement with a total gross policy premium and related fees of $4,812 and financed $4,461 of it. Hydroman needs to pay a monthly installment of $481 for ten months with the last installment due on December 13, 2023. The effective interest rate of this loan was 16.85%. The Company terminated the insurance policy and this loan on June 15, 2023. During the three and nine months ended September 30, 2023, the Company paid $0 and $4,812 principal of the loan, respectively.

  

Short-term loans — related parties: refer to Note 12 Related Party transactions.

 

Interest expenses for short term loans amounted to $376,794 and $805,009 during the three and nine months ended September 30, 2024, respectively.

 

Interest expenses for short term loans amounted to $98,490 and $480,304 during the three and nine months ended September 30, 2023, respectively.

 

Long-term debts:

 

Long-term debts consist of three auto loans, one building loan, and one secured business loan as of September 30, 2024 and December 31, 2023.

 

The outstanding amount of the auto loans were $89,898 and $114,621 as of September 30, 2024 and December 31, 2023, respectively. On February 27, 2021, the Company purchased a vehicle for $68,802 and financed $55,202 of the purchase price through an auto loan. The loan requires monthly installment payment of $1,014 with the last installment due on February 28, 2026. On June 8, 2021, the Company purchased the second vehicle for $86,114 and financed $73,814 of the purchase price through auto loan. The loan requires monthly installment payment of $1,172 with the last installment due on June 23, 2027. On September 28, 2022, the Company purchased the third vehicle for $62,230 and financed $56,440 of the purchase price through auto loan. The loan requires a monthly installment payment of $1,107 with the last installment due on September 28, 2027. During the three and nine months ended September 30, 2024, the Company made total payments of $7,743 and $24,723 towards the auto loans, respectively. During the three and nine months ended September 30, 2023, the Company made total payments of $8,230 and $24,398 towards the auto loans, respectively.

 

Minimum required principal payments towards the Company’s auto loans as of September 30, 2024 are as follows:

 

Twelve months ended September 30,  Repayment 
2025  $36,581 
2026   30,313 
2027   23,004 
Total  $89,898 

  

The outstanding amount of the building loan was $2,792,528 and $2,852,597 as of September 30, 2024 and December 31, 2023, respectively. On January 10, 2022, the Company purchased one building and land for $4,395,230 and financed $3,000,000 of the purchase price through Bank of the west. The loan requires monthly installment payment of $15,165 with the last installment due on January 10, 2032. During the three and nine months ended September 30, 2024, the Company made total payments of $20,113 and $60,070 towards the loan, respectively. During the three and nine months ended September 30, 2023, the Company made total payments of $19,394 and $58,225 towards the loan, respectively.

 

21

 

 

Minimum required principal payments towards the Company’s building loan as of September 30, 2024 are as follows:

 

Twelve months ended September 30,   Repayment  
2025   $ 83,122  
2026     86,155  
2027     89,298  
Thereafter     2,533,953  
Total   $ 2,792,528  

 

The outstanding amount of the secured business loan was $3,168,575 and $3,281,526 as of September 30, 2024 and December 31, 2023, respectively. On June 14, 2023, the Company’s subsidiaries Visiontech and Hydroman entered into a secured business loan agreement with Newtek Business Services Holdco 6, Inc. for a principal sum of up to $3,700,000 with a maturity date of July 1, 2033. The loan is secured by the Company’s building and guaranteed by the Company’s major stockholders. During the three and nine months ended September 30, 2024, the Company made total payments of $39,199 and $112,951 towards the loan, respectively. During the three and nine months ended September 30, 2023, the Company made total payments of $31,534 and $31,354 towards the loan, respectively.

 

Minimum required principal payments towards the Company’s secured business loan as of September 30, 2024 are as follows:

 

Twelve months ended September 30,  Repayment 
2025  $173,838 
2026   204,702 
2027   241,047 
Thereafter   2,548,988 
Total  $3,168,575 

 

Interest expenses for long term loans amounted to $157,506 and $477,809 during the three and nine months ended September 30, 2024, respectively.

 

Interest expenses for long term loans amounted to $34,558 and $91,152 during the three and nine months ended September 30, 2023, respectively.

 

Note 11 — Convertible notes

 

The Company entered into a series of convertible note agreements with investors as described below. The Company also determined that the embedded conversions in the notes meets the scope exception to be considered indexed to a reporting’s own stock based on the two-step approach in accordance with ASC 815-40-15 and does not require to be separately accounted for as a derivative. As a result, the Company classified all the convertible notes as a debt instrument in its entirely.

 

On July 3, 2024, the Company signed four convertible note agreements total of $410,000 from four investors. Each note bears 12% interest per annum and matures in 6 months. The Company shall repay the principal and accumulated interest after six months. If the investors choose to convert, the number of shares will be calculated by dividing the principal plus accumulated interest by $0.442. $410,000 had been deposited into the Company’s bank account in July 2024. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the notes.

 

22

 

 

On July 17, 2024, the Company entered into a securities purchase agreement with a certain investor pursuant to which the Company sold, in a private placement, a $180,000 convertible note with an original issue discount of $27,500, and a warrant to purchase up to 217,500 shares of common stock at an exercise price of $0.87 per share. As consideration for entering into the securities purchase agreement, the Company issued a total of 180,000 shares to the investor on July 19, 2024. The warrant is exercisable on July 17, 2024 until five years from July 17, 2024. Approximately $58,090 from the convertible note proceeds was allocated to issuance of ordinary shares and warrants based on relative fair value. On July 30, 2024, the note was terminated as a result of the Company’s full payment of the note’s principal amount. As a result, all obligations under the note have been satisfied, and the note is no longer outstanding.

 

On August 13, 2024, the Company entered a securities purchase agreement with 1800 Diagonal Lending LLC (“Diagonal”), in connection with the issuance of a promissory note in the aggregate principal amount of $181,700, including an original issue discount of $23,700, closing expenses of $8,000 deducted from funding amount; with additional tranches of financing of up to $1.0 million in the aggregate during the next twelve months subject to further agreement by and between Diagonal and the Company. The initial funding shall be payable in 10 equal monthly installments of $20,350. Only upon an occurrence of an event of default under the note, the holder may convert the outstanding unpaid principal amount of the note into shares of common stock of the Company at a discount of 25% of the market price.  For the three and nine months ended September 30, 2024, the Company paid $18,170 and $18,170 principal of the note.

 

On September 18, 2024, the Company entered into another securities purchase agreement with Diagonal pursuant to which the Company sold to the Diagonal a convertible promissory note in the aggregate principal amount of $107,880 with an original issue discount of $14,880. The offering closed on September 20, 2024. For the three and nine months ended September 30, 2024, the Company paid $0 and $0 principal of the note.

 

Interest expenses in connection with the convertible notes for the three and nine months ended September 30, 2024 amounted to $129,218 and $129,218, respectively.

 

Note 12 — Related party transactions

 

Purchases and accounts payable – related parties:

 

UniNet Global Inc. (“Uninet”), a vendor whose stockholder is Zhiyi (Jonathan) Zhang who is also one of the stockholders and management of the Company, sold certain products to Visiontech. On September 24, 2024, the Company entered into a trade payable forgiveness agreement with Visiontech, Uninet and NMI, relating to the cancellation of a portion of outstanding trade payables owed by Visiontech to Uninet. Visiontech owed Uninet a trade payable in the amount of $2,713,073 as of June 30, 2024. Pursuant to the trade payable forgiveness agreement, Uninet agreed to cancel the outstanding trade payable of $2,135,573, leaving a remaining balance of $577,500 still payable by Visiontech to Uninet. The debt forgiveness was recorded as an increase in additional paid in capital of $2,135,573 as a result of related party transaction. On July 29, 2024, Visiontech made a payment of $5,000 to Uninet. As of September 30, 2024 and December 31, 2023, the outstanding accounts payable amount due to Uninet was $572,500 and $2,758,074, respectively. 

 

From 2022 to April 2023, Jinlong (David) Du, the CEO of Megaphoton, was also the Director of NMI and will serve as Director of the Company following the Merger with Lakeshore. On April 17, 2023, Jinlong Du resigned from his position as a member of the NMI’s board of director and will not serve as the Company’s director post merger. For the four months ended April 30, 2023, the purchases Visiontech made from Megaphoton was $92,416 and the purchases Hydroman made from Megaphoton was $0. Hydroman and Megaphoton ended the exclusive supplier agreement on May 4, 2023. 

  

On April 11, 2023, one of the Company’s customers and vendors, Iluminar Lighting LLC (“Iluminar”) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminar’s outstanding shares. During the three and nine months ended September 30, 2024, the purchases made from Iluminar was $0 and $1,160, respectively. During the three and nine months ended September 30, 2023, the purchases made from Iluminar was $0 and $0, respectively.

 

23

 

 

Revenue and accounts receivable - related party:

 

During the three and nine months ended September 30, 2024, the sales revenue from Iluminar was $1,135,628 and $2,129,726, respectively. During the three and nine months ended September 30, 2023, the sales revenue from Iluminar was $10,425 and $35,522, respectively. As of September 30, 2024 and December 31, 2023, the account receivable from Iluminar was $1,850,601 and $305,669, respectively. 

 

Deferred income – contract liabilities - related party:

 

As of September 30, 2024 and December 31, 2023, the deferred income - contract liabilities from Iluminar was $64,468 and $0, respectively. 

 

Other payables — related parties

 

For the year ended December 31, 2022, Nature’s Miracle Inc. (Cayman) (“NMCayman”), former stockholders of NMI, currently under common control of Mr. Tie (James) Li, the Company’s CEO, paid a total amount of $345,000 of legal and audit fee for the Company. As of September 30, 2024 and December 31, 2023, the outstanding amount due to NMCayman was $170,000 and $170,000, respectively.

 

For the year ended December 31, 2021, Yang Wei, former shareholder of the Visiontech and current shareholder of the Company, paid a total amount of $23,813 of normal business operating fee for the Company. As of September 30, 2024 and December 31, 2023, the outstanding amount due to Yang Wei was $23,813 and $23,813, respectively.

 

For the year ended December 31, 2022, Zhiyi (Jonathan) Zhang, paid a total amount of $27,944 of normal business operating fee for the Company. On May 19, 2023, September 4, 2023, and July 1, 2024, Zhiyi (Jonathan) Zhang paid another $1,000,$557, $8,184 for normal business operating expenses, respectively. On October 11, 2023, the Company paid off $28,501 of the balance. As of September 30, 2024 and December 31, 2023, the outstanding amount due to Zhiyi (Jonathan) Zhang was $9,184 and $1,000.

 

In September 2024, James Li paid a total amount of $30,000 of normal business operating fee for the NMCA. As of September 30, 2024, the outstanding amount due to James Li was $30,000.

 

As of September 30, 2024 and December 31, 2023, accrued interest expense from related parties, were $115,661 and $63,141, respectively, which were included in other payable related parties on the Company’s balance sheets. (see Short-term loans — related parties for detail).

  

Loan receivable — related parties:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
Loan to Lakeshore Acquisition II Corp.  $            -   $460,000 
Total loan receivable – related parties  $-   $460,000 

 

On June 8, 2023, the Company and Lakeshore entered into a promissory note for the principal amount of $40,000 with zero interest rate.

 

On July 7, 2023, August 10, 2023, September 11, 2023, October 11, 2023 and November 9, 2023, NMI and Lakeshore entered into five promissory notes for the principal amount of $80,000 each with zero interest rate.

 

On December 7, 2023, January 8, 2024, and February 6, 2024, NMI and Lakeshore entered into three promissory notes pursuant to which Lakeshore borrowed the principal amount of $20,000 each with zero interest rate.

 

As a result of the Merger, all loans to Lakeshore had been consolidated and eliminated on the Company’s unaudited condensed consolidated balance sheets.

 

Interest income for loan receivable – related parties amounted to $0 and $0 during the three and nine months ended September 30, 2024, respectively.

  

Interest income for loan receivable – related parties amounted to $2,218 and $4,643 during the three and nine months ended September 30, 2023, respectively.

 

24

 

 

Short-term loans — related parties

 

On November 29, 2022, Visiontech signed a loan with Zhiyi (Jonathan) Zhang, one of the stockholders of the Company, for the principal amount of $100,000 with 8% interest rate. This loan is originally required to be paid in full before May 29, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently further extended to August 15, 2024, and finally extended to April 15, 2025. During the year ended December 31, 2023, the Company paid $40,000 to Zhiyi Zhang. The loan balance as of September 30, 2024 and December 31, 2023 was $60,000 and $60,000. As of September 30, 2024 and December 31, 2023, the accrued interest of this loan was $10,849 and $7,186, respectively.

 

In December 2022, the Company signed two loans with Tie (James) Li, the Company’s CEO, for the total principal amount of $610,000 with 8% interest rate. This loan is originally required to be paid in full before June 1, 2023, the Company initially extended it to November 15, 2023. The Company made $500,000 payments towards the loan on June 16, 2023. The $110,000 loan was further extended to February 15, 2024, subsequently extended to August 15, 2024, and finally extended to April 15, 2025. The loan balance as of September 30, 2024 and December 31, 2023 was $60,000 and $110,000, respectively. The accrued interest of this loan as of September 30, 2024 and December 31, 2023 was $15,400 and $8,800, respectively.

 

On July 11, 2023, Lakeshore signed one loan with Tie (James) Li for a principal amount of $125,000 with 8% interest rate. This loan was required to be paid in full before November 11, 2023. On December 8, 2023, Lakeshore entered into a side letter to this loan agreement to extend the repayment to March 11, 2024 and agree to waive any and all interest and penalties that may have accrued commencing on November 11, 2023. This loan was subsequently extended to September 15, 2024 and finally extended to April 15, 2025. The loan balance as of September 30, 2024 and December 31, 2023 was $125,000 and $0, respectively. As of September 30, 2024, accrued interest of this loan was $5,562.

 

On January 17, 2023, the Company and NMCayman, one of the stockholders of the Company, entered into a loan agreement for the principal amount of $318,270 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024, and finally extended to April 15, 2025. As of September 30, 2024 and December 31, 2023, accrued interest of this loan was $43,517 and $24,276.

 

On January 17, 2023, the Company and NMCayman entered into a loan agreement for the principal amount of $294,985 with 8% interest rate. This loan is originally required to be paid in full before July 17, 2023, the Company initially extended it to November 15, 2023, further extended to February 15, 2024, subsequently extended to August 15, 2024, and finally extended to April 15, 2025. As of September 30, 2024 and December 31, 2023, the accrued interest of this loan was $40,333 and $22,500.

  

On April 1, 2023, NMI and NMCayman entered into a loan agreement for the principal amount of $160,000 with 8% interest rate. This loan had been paid in full on June 13, 2023.

 

Interest expense for short-term loan - related parties amounted to $18,316 and $52,519 during the three and nine months ended September 30 2024, respectively.

 

Interest expense for short-term loan - related parties amounted to $42,381 and $68,414 during the three and nine months ended September 30 2023, respectively.

 

Note 13 — Income taxes

 

As of September 30, 2024 and December 31, 2023, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate for the three and nine months ended September 30, 2024 were 0.0% and 0.0%, respectively. The effective tax rate for the three and nine months ended September 30, 2023 were 27.8% and 21.9%, respectively. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets.

  

25

 

 

Note 14 — Equity

 

Reverse recapitalization

 

The total number of shares which the Company shall have the authority to issue is one hundred and ten million (110,000,000) shares of two classes of capital stock to be designated respectively preferred stock (“Preferred Stock”) and common stock (“Common Stock”). The total number of shares of Common Stock the Corporation shall have authority to issue is 100,000,000 shares, par value $0.0001 per share. The total number of shares of Preferred Stock the Corporation shall have authority to issue is 10,000,000 shares, par value $0.0001 per share. The Preferred Stock authorized by this Certificate of Incorporation may be issued in series. As a result of the Merger as described in note 1, all share and per share data has been retroactively restated to reflect the current capital structure of the Company.

 

Shares issued in connection with the Company’s Merger on March 11, 2024:

 

   Common
Stock
 
Lakeshore’s shares outstanding prior to reverse recapitalization   2,241,500 
Shares issued to private rights   35,150 
Conversion of the Lakeshore’s public shares and rights   790,097 
Shares issued to service providers   801,539 
Bonus shares issued to in connection with Lakeshore loans *   66,000 
Bonus shares issued to in connection with NMI loans *   100,000 
Conversion of NMI’s shares into the Company’s ordinary shares   22,272,478 
Total shares outstanding   26,306,764 

 

* In connection with the Merger, the Company, Lakeshore and NMI further entered into a Letter Agreement on November 15, 2023, a total of 125,000 shares of the Company’s common stock will be issued upon closing of the Merger in connection with certain transactions relating to the Merger: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi (Jonathan) Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of NMI with the principal amount of $3,700,000; (ii) 12,500 shares to Tie (James) Li and 12,500 shares to Deyin (Bill) Chen (or 25,000 shares in the aggregate) in connection with their loans to Lakeshore, each with the principal amount of $125,000 under separate but similar loan agreements); At the Close of Merger, additional shares of 16,000 and 25,000 were issued to Tie (James) Li and Prosperity Spring International Investment Management in connection with their loans to Lakeshore.

 

The shares were valued $10 per share, of which $1.0 million (100,000 shares awarded pertaining to loan guarantee for the Newtek loan) was expensed as finance expense in the Company unaudited condensed consolidated statements of operations during the nine months ended September 30, 2024. $660,000 was expensed in Lakeshore’s statements of operations and carried over as retained deficit after the Merger. The shares in connection with the loans have been issued during the close of the Merger.

  

Stock compensation

 

In connection with the Merger, the Company adopted the Equity Incentive Plan (the “2024 Incentive Plan”).

 

The 2024 Incentive Plan will provide for grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or equity-related cash-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing consulting or advisory services for the Company, will be eligible for grants under the 2024 Incentive Plan.

 

The 2024 Incentive Plan provides for the future issuance of shares of the Company’s Common Stock, representing 10% of the number of shares of the Company’s Common Stock outstanding following the Business Combination (after giving effect to the Redemption). The 2024 Incentive Plan also provides for an annual increase on January 1 for each of the first ten (10) calendar years during the term of the 2024 Incentive Plan by the lesser of (a) Five percent (5%) of all classes of the Company’s common stock outstanding on each December 31 immediately prior to the date of increase or (b) such number of Shares determined by the Board.  

 

26

 

 

Pursuant to board resolution dated August 23, 2023, the Company is to grant a one-time award of 10,000 shares of common stock of the company to Charles Hausman, a Director of the Company; a one-time award of 50,000 shares of the company to Tie “James” Li and a one-time award of 50,000 shares of the company to Zhiyi Zhang, both executives of the Company. The above awards are vested immediately upon consummation of the business combination with Lakeshore.

 

Pursuant to board resolution dated September 20, 2023, the Company approved a stock grant to Mr. Darin Carpenter, Chief Operating Officer of the Company, pursuant to which Mr. Carpenter will be issued 100,000 shares of the Company’s common stock over a two-year service period upon consummation of the business combination Lakeshore.

 

On August 1, 2024, the Company and Darin Carpenter entered into the mutual termination of employment agreement and intent to transition to project-based work (the “Agreement”), in which it was agreed that Mr. Carpenter shall resign from his position as Chief Operating Officer of the Company effective as of July 31, 2024. Pursuant to the Agreement, the Company and Mr. Carpenter agreed that Mr. Carpenter will provide services as a consultant to the Company on a per project basis as needed. In addition, the Company agreed to fully vest 100,013 shares of common stock that was issuable to Mr. Carpenter pursuant to the Employment Agreement dated as of September 17, 2023, by and between the Company and Mr. Carpenter. The Company also agreed to pay Mr. Carpenter the equivalent of one month of salary payable in September 2024.

 

Shares award to Mr. Hausman and Mr. Carpenter per Letter Agreement stated above has a fair value of $1.1 million and were expensed as compensation expenses according to vesting terms.

 

Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 100,000, 50,000 and 50,000 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. The fair value of the shares to be issued was approximately $178,000 at $0.89 per share.

 

On April 2, 2024, the Company entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to the company and the agreement has a term of six months. The Company will pay $14,000 cash per month and to issue MZHCI 150,000 shares of restricted common stock, 75,000 shares will be vested immediately upon signing the agreement and 75,000 shares will vest on October 1, 2024. The fair value of the shares was approximately $143,000 at $0.95 per share. The 150,000 shares were issued on May 7, 2024.

 

For the three and nine months ended September 30, 2024, the Company recorded stock compensation expenses of $848,075 and $1,215,880, respectively. Those stock compensation expenses are included in the Company’s operating expenses.

 

Shares issued with July convertible notes

 

On July 19, 2024, the Company issued a total of 180,000 shares to the investor pursuant to a securities purchase agreement (See Note 11 on Convertible notes for detail). The fair value of the shares was approximately $81,000 at $0.45 per share.

 

Public Offering

 

On July 29, 2024, the Company closed an underwriting public offering for the sale of 5,000,000 units at a public offering price of $0.24 per unit, with each unit consisting of: (i) one share of common stock and (ii) one warrant to purchase one share of common stock, for aggregate net proceeds of $1.2 million after deducting underwriting discounts and other offering expenses. The warrant is immediately exercisable on the date of issuance at an exercise price of $0.24 per share and expires five years from the closing date of the offering.

 

Warrants:

 

Warrants issued prior to reverse recapitalization

 

In connection with the reverse recapitalization, the Company has assumed 3,625,750 warrants outstanding, which consisted of 3,450,000 public warrants and 175,750 private warrants. Both of the public warrants and private warrant met the criteria for equity classification.

 

Each whole warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, commencing 30 days after the completion of its initial business combination, and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade.

 

27

 

 

The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise. If an initial business combination is not consummated, the warrants will expire and will be worthless.

  

In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at a newly issued price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founders’ shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the Company’s initial business combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the market value and the newly issued price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price.

 

Warrant issued with July convertible notes

 

On July 17, 2024, the Company issued a total of 217,500 warrants in connection with a securities purchase agreement, granting the option to purchase up to 217,500 shares of common stock at an exercise price of $0.87 per share. The warrant is exercisable on July 17, 2024 until five years from July 17, 2024 (See Note 11 on Convertible note for detail). The fair value of the warrants was approximately $4,600 at $0.02 per warrant.

 

The issuance of the warrants described above were deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder in that the issuance of securities were made to an accredited investor and did not involve a public offering. The recipient of such securities represented its intention to acquire the securities for investment purposes only and not with a view to or for sale in connection with any distribution thereof.

 

The total number of these warrant shares is subject to adjustments for stock splits, recapitalizations and reorganizations. If the Company issues or sells any shares of common stock or other securities for a price per share, exercise price, or conversion price, as the case may be, that is less than the current exercise price of the warrant, subject to exceptions, the exercise price of the warrant will be adjusted to match the price per share, exercise price, or conversion price, in the issuance, as applicable.

 

Series A Warrant issued in July Public offering

 

On July 29, 2024, the Company issued a total 5,000,000 Series A warrant, each entitling the holder to purchase one share of common stock at a public offering price of $0.24 per unit. The Series A warrant is immediately exercisable on the date of issuance at an exercise price of $0.24 per share and expires five years from the closing date of the offering (See above Public Offering for detail). The fair value of the warrants was approximately $100,500 at $0.02 per warrant.

 

28

 

 

The Series A warrants are exercisable at any time after their original issuance up to the date that is five years after their original issuance. The Series A warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompanied by payment in full in immediately available funds for the number of shares of Common Stock subscribed for upon such exercise (except in the case of a cashless exercise as discussed below). If a registration statement registering the issuance of the shares of Common Stock underlying the Series A warrants under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Series A warrants through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Series A warrants.

 

The exercise price per whole share of Common Stock issuable upon exercise of Series A warrants is $0.24 per share. The exercise price and number of shares of Common Stock issuable upon exercise will adjust in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications, dilutive issuances or similar events. In addition, with respect to Series A warrants, subject to certain exemptions outlined in the Series A warrants, if we sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any shares of Common Stock, at an effective price per share less than the exercise price of the Series A warrants then in effect, the exercise price of the Series A warrants shall be reduced to equal the effective price per share in such dilutive issuance, provided, however, in no event shall the exercise price of the Series A warrants be less than $0.05.

 

The summary of warrants activity is as follows:

 

   Warrants
Outstanding
   Common Stock
Issuable
   Weighted
Average
Exercise
Price
   Average
Remaining
Contractual
Life
(in years)
 
           US$     
December 31, 2023   -    -   $-    - 
Converted upon the reverse recapitalization   3,625,750    3,625,750   $11.50    5.00 
Forfeited   -    -   $-    - 
Exercised   -    -   $-    - 
March 31, 2024   3,625,750    3,625,750   $11.50    4.95 
Granted   -    -   $-    - 
Forfeited   -    -   $-    - 
Exercised   -    -   $-    - 
June 30, 2024   3,625,750    3,625,750   $11.50    4.70 
Granted   5,217,500    5,217,500   $0.27    5.00 
Forfeited   -    -   $-    - 
Exercised   -    -   $-    - 
September 30, 2024   8,843,250    8,843,250   $4.87    4.67 

 

29

 

 

Note 15 — Concentration of risk

 

Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

 

As of September 30, 2024 and December 31, 2023, $38,820 and $219,553, respectively, were deposited with various major financial institutions in the United States.

 

Accounts receivable is typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances. The Company maintains reserves for estimated credit losses, and such losses have generally been within expectations.

 

Customer and vendor concentration risk

 

During the three and nine months ended September 30, 2024 and during the three and nine months ended September 30, 2023, the major customers of the Company are as below. Iluminar is a related party of the Company since April 11, 2023, as disclosed in Note 12— Related party transactions.

 

   For the
three months
ended
September 30,
2024
   For the
nine months
ended
September 30,
2024
   As of
September 30,
2024
 
   Percentage of
Revenue
   Percentage of
Revenue
   Percentage of
Account Receivable
 
Illuminar   37%   25%   43%
Customer A   15%   21%   37%
Customer C   <10%   10%   <10%

 

    For the
three months
ended
September 30,
2023
    For the
nine months
ended
September 30,
2023
    As of
December 31,
2023
 
    Percentage of
Revenue
    Percentage of
Revenue
    Percentage of
Account Receivable
 
Customer C                <10 %              13 %                     13 %
Customer G     19 %     <10 %     31 %
Customer H     <10 %     <10 %     12 %
Customer I     11 %     <10 %     10 %
Iluminar     <10 %     <10 %     18 %
Customer E     <10 %     10 %     <10 %
Customer J     11 %     <10 %     10 %

 

30

 

 

During the three and nine months ended September 30, 2024 and during the three and nine months ended September 30, 2023, the major vendors of the Company are as below. Both Megaphoton and Uninet Global Inc. are related parties of the Company (Megaphoton is no longer a related party of the Company after April 2023), as disclosed in Note 12— Related party transactions, and all purchases from Uninet Global Inc. are products originally manufactured by Megaphoton Inc.

 

   For the
three months
ended
September 30,
2024
   For the
nine months
ended
September 30,
2024
   As of
September 30,
2024
 
   Percentage of
Purchase
   Percentage of
Purchase
   Percentage of
Account Payable
 
Megaphoton Inc.   <10%   <10%   62%
Vendor A   31%   42%   <10%
Vendor B   25%   <10%   <10%
Vendor E   18%   31%   15%
Vendor F   11%   <10%   <10%

 

    For the
three months
ended
September 30,
2023
    For the
nine months
ended
September 30,
2023
    As of
December 31,
2023
 
    Percentage of
Purchase
    Percentage of
Purchase
    Percentage of
Account Payable
 
Vendor A     75 %     63 %                       <10 %
Vendor B     10 %     <10 %     <10 %
Megaphoton Inc.     <10 %     <10 %     62 %
UniNet Global Inc.     <10 %     <10 %     20 %

  

Note 16 — Lease

 

The Company follows ASC 842 Leases. The Company has entered into lease agreements for vehicles, offices and warehouses space in California, Pennsylvania and Texas. $582,890 and $503,089 of operating lease right-of-use assets and $686,457 and $517,356 of operating lease liabilities were reflected on the September 30, 2024 and December 31, 2023 financial statements, respectively.

 

On January 28, 2021, Hydroman entered into a lease agreement of the warehouse in Texas. The lease term was from February 1, 2021 to February 29, 2024 and the month from February 1, 2021 to February 28, 2021 was free of charge. The lease payments are $6,750 per month for the period commencing March 1, 2021 and ending February 28, 2022, $6,920 per month for the period commencing March 1, 2022 and ending February 28, 2023, $7,100 per month for the period commencing March 1, 2023 and ending February 29, 2024. The lease was terminated in May 2023.

 

On April 14, 2021, Hydroman entered into a lease agreement of the warehouse in Pennsylvania. The lease term was from May 1, 2021 to April 30, 2024 and the month from May 1, 2021 to May 31, 2021 was free of charge. The lease payments are $6,300 per month for the period commencing June 1, 2021 and ending May 31, 2022, $6,452 per month for the period commencing June 1, 2022 and ending May 31, 2023, $6,609 per month for the period commencing June 1, 2023 and ending May 31, 2024. The lease was terminated on March 2023.

 

31

 

 

On May 15, 2021, Hydroman entered into a lease agreement of the warehouse in California. The lease term was from May 16, 2021 to May 15, 2022. The lease payments are $22,375 per month. On May 15, 2021, Hydroman entered into a sublease agreement of this warehouse with McLovin’s Pet Food Inc.. The sublease term was from May 16, 2021 to May 15, 2022. The payments of the sublease are $2,885 per month. On May 16, 2022, Hydroman extended the lease of the warehouse in California. The new leasing term was from June 16, 2022 to June 15, 2025 and an extra month from May 16, 2022 to June 15, 2022 free of charge. The lease payments are $29,088 per month for the period commencing June 16, 2022 and ending June 15, 2023, $29,960 per month for the period commencing June 16, 2023 and ending June 15, 2024, $30,859 per month for the period commencing June 16, 2024 and ending June 15, 2025. The corresponding sublease with McLovin’s Pet Food Inc. was also extended from May 16, 2022 to May 15, 2025. The payments of the sublease are $3,751 per month for the period commencing May 16, 2022 and ending May 15, 2023, $3,863 per month for the period commencing May16, 2023 and ending May 15, 2024, $3,979 per month for the period commencing May 16, 2024 and ending May 15, 2025. The sublease was terminated in January 2023.

 

On September 1, 2022, Photon Technology Ltd entered into a year-to-year lease agreement for an office located in Canada. The term of the lease commenced on September 1, 2022. The monthly payment was CAD 3,500 (USD $2,690). The lease was terminated in March 2023.

 

On September 21, 2022, NMI entered into a month-to-month lease agreement for an office located in California. The term of the lease commenced on September 21, 2022. The monthly payment was $2,333. The lease was terminated in December 2023. 

 

On May 28, 2023, Visiontech entered into a lease agreement for a vehicle. The leasing term began on May 28, 2023 and will terminate on April 28, 2025 with a first installment of $15,000 and then continuously monthly payment of $1,550.

 

On April 11, 2024, the Company entered into a lease agreement for an office located in California. The lease term was from May 1, 2024 to April 30, 2027. The lease payments are $8,528 per month for the period commencing May 1, 2024 and ending April 30, 2025, $8,784 per month for the period commencing May 1, 2025 and ending April 30, 2026, $9,047 per month for the period commencing May 1, 2026 and ending April 30, 2027.

 

On July 20, 2024, Visiontech entered into a lease agreement for another vehicle. The leasing term began on September 3, 2024 and will terminate on August 3, 2028 with a first installment of $16,100 and then continuously monthly payment of $2,403.

 

As of September 30, 2024 and December 31, 2023, the weighted-average remaining operating lease term of its existing leases is approximately 2.52 and 1.45 years, respectively. As of September 30, 2024 and December 31, 2023, the average discount rate of its existing leases is approximately 7.10% and 6.81%, respectively.

 

   For the
Three Months Ended
   For the
Nine Months Ended
 
   September 30,
2024
   September 30,
2023
   September 30,
2024
   September 30,
2023
 
Lease cost  (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Operating lease cost (included in Cost of Revenue and Other Expense in the Company’s Statement of Operations)  $119,263   $93,821   $287,508   $335,566 
Other information                    
Cash paid for amounts included in the measurement of lease liabilities   81,974    99,778    198,208    353,350 

 

The supplemental balance sheet information related to leases for the period is as follows:

 

   As of
September 30,
2024
   As of
December 31,
2023
 
Operating leases        
Right of use asset   582,890    503,089 
Lease Liability – current portion   451,417    359,459 
Lease Liability – net of current portion   235,040    157,897 
Total operating lease liabilities  $686,457   $517,356 

 

32

 

 

Maturities of the Company’s lease liabilities are as follows:

 

Twelve months ended September 30,  Operating
Lease
 
2025  $482,741 
2026   135,554 
2027   92,163 
Thereafter   26,431 
Less: Imputed interest/present value discount   (50,432)
Present value of lease liabilities  $686,457 

 

Note 17 — Contingencies

 

The Company may, from time to time, be involved in legal matters arising in the ordinary course of its business. While the Company is not presently subject to any material legal proceedings, there can be no assurance that such matters will not arise in the future or that any such matters in which the Company is involved, or which may arise in the ordinary course of the Company’s business, will not at some point proceed to litigation or that such litigation will not have a material adverse effect on the business, financial condition or results of operations of the Company.

 

On August 22, 2023, two separate lawsuits were filed against NMI and two of its wholly-owned subsidiaries: Visiontech Group Inc., a California corporation, and Hydroman Inc., a California corporation (collectively referred to as the “Defendants”) by Megaphoton. Megaphoton, a manufacturer and producer of artificial lighting equipment for use in agriculture and industrial applications, filed the lawsuits against the Defendants in Los Angeles Superior Court, asserting that the Defendants have breached a contract/guarantee agreement by failing to pay a total of $6,857,167, as per the terms of these agreements. NMI believes that there is no merit in the complaint and has filed a counter-suit against Megaphoton in Orange County Court, California, seeking affirmative relief on September 22, 2023. On March 5, 2024, Megaphoton filed requests to dismiss the cases against Hydroman and Visiontech in the Superior Court of Los Angeles.

 

On March 1, 2024 NMI was notified of a complaint in San Bernardino Superior Court by Vien Le, its former CFO, who was employed approximately 2 months. The lawsuit claims wrongful discharge, untimely payment of wages and other related items. The Company has retained counsel and believes it will successfully defend against this lawsuit.

 

Nasdaq Notification Letter

 

On April 26, 2024, the “Company received a notification letter (the “Notification Letter on MVPHS”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum Market Value of Publicly Held Shares (the “MVPHS”) set forth in Nasdaq Listing Rule 5450(b)(2)(C) for continued listing on Nasdaq, which requires a minimum MVPHS of $15,000,000 (the “MVPHS Requirement”), since the Company failed to meet the MVPHS Requirement for a period of 30 consecutive business days from March 13, 2024 to April 25, 2024. The Notification Letter on MVPHS has no immediate effect on the listing or trading of the common stock, par value $0.0001 per share, of the Company (“Common Stock”) on Nasdaq and, as of April 26, 2024, the Common Stock will continue to trade on Nasdaq under the symbol “NMHI.”

 

Additionally, on April 26, 2024, the Company received a separate notification letter (the “Notification Letter on MVLS”) from Nasdaq, indicating that the Company was no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”) since the Company failed to meet the MVLS Requirement for a period of 30 consecutive business days from March 13, 2024 to April 25, 2024. The Notification Letter on MVLS has no immediate effect on the listing or trading of the Common Stock on Nasdaq and, as of April 26, 2024, the Common Stock will continue to trade on Nasdaq under the symbol “NMHI.”

 

The Company has a period of 180 calendar days, or until October 23, 2024, to regain compliance with the Requirements.

 

On May 23, 2024, the Company received another notice from Nasdaq, notifying the Company that, because the closing bid price for the Common Stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Rule 5450(a)(1) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s Common Stock on the Nasdaq Global Market. Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until November 20, 2024, to regain compliance with the minimum bid price requirement.

 

33

 

 

The Company intends to monitor the MVPHS Requirement, MVLS Requirement, and minimum bid price requirement of its Common Stock and will consider implementing available options to regain compliance with the MVPHS Requirement, MVLS Requirement and minimum bid price requirement under the Nasdaq Listing Rules.

 

The Company intends to monitor the MVPHS Requirement and MVLS Requirement of its Common Stock and will consider implementing available options to regain compliance with the MVPHS Requirement and MVLS Requirement under the Nasdaq Listing Rules.

 

Note 18 — Subsequent events

 

On October 14, 2024, the Company issued and sold to an investor a promissory note in the principal amount of $101,200 (reflecting a purchase price of $88,000 and an original issue discount of $13,200) (the “October 2024 Private Placement”). The note bears a one-time interest charge of 14% of the principal amount. Accrued, unpaid interest and outstanding principal will be due in ten payments, each in the amount of $11,536.80. The first payment will be due November 15, 2024 with nine subsequent payments due on the 15th of each month thereafter. Only upon occurrence of an event of default under the note, the note will be convertible into common stock at a conversion price equal to 75% multiplied by the lowest trading price for the common stock during the ten trading days prior to the conversion date.

 

On October 18, 2024, NM Rebate, Inc.(“NM Rebate”), a California corporation wholly owned by NMI was incorporated. NM Rebate focus on energy rebate solutions combined with the supply of LED lights that qualify for energy-saving rebates provided by large Utility companies throughout the U.S.

 

On October 24, 2024, the Company received a notification letter from with The Nasdaq Stock Market LLC (“Nasdaq”) (the “Delisting Notice”) notifying the Company that, as a result of the Company’s failure to regain compliance with Nasdaq’s continued listing requirements under Nasdaq’s Listing Rule 5450(b)(2)(A), requiring the market value of listed securities to be at least $50,000,000 for continued listing (the “MVLS Rule”), and Listing Rule 5450(b)(1)(C) requiring the market value of its publicly held shares to be at least $5,000,000 for continued listing (the “MVPHS Rule”) under Listing Rule 5450(b)(1)(C) (the “MVPHS Rule”) by the previously imposed deadline of October 23, 2024, Nasdaq has determined to delist the Company’s common stock from the Nasdaq Global Market.

 

On October 30, 2024, the Company submitted a request for a hearing to appeal this determination. The hearing request stays the suspension of the Company’s securities. At the hearing, which will be held on December 17, 2024, the Company will present a plan to regain compliance, and request an extension to demonstrate compliance with the Nasdaq continued listing requirements.

 

Pursuant to board resolution dated October 25, 2024, the Company approved the issuance of 400,000 restricted shares of common stock, par value $0.0001 per share to Alta Waterford LLC for service provided related to digital advertising and social media platform. The shares shall be issued pursuant to the 2024 Incentive Plan. The fair value of the shares was approximately $58,000 at $0.15 per share.

 

On October 22, 2024, Growterra, LLC (“Growterra”) filed a complaint against the Company and the Company’s chief executive officer in the Court of Common Pleas, Hamilton County, Ohio, alleging that it purchased lighting products from the Company, under which the Company would provide Growterra software, IP, and design documentation related to hydroponic containers and identify Growterra as an additional insured on the Company’s product liability insurance. Growterra alleges the Company failed to perform these obligations. Growterra is alleging breach of contract, fraud, and misappropriation of trade secrets as well as related causes of action. Growterra does not state an amount of damages but is also seeking rescission. The Company has not yet answered.

 

On October 30, 2024, Visiontech filed a cross-complaint against Beverly Hills View, Inc. (“BHV”) in Los Angeles Superior Court. This action responded to an initial lawsuit filed by BHV on August 29, 2024, in which BHV claimed that the lighting products received were unsuitable for its cannabis growing operation and claiming damages of $2,500,000

 

On November 7, 2024, the Company entered into an underwriting agreement with D. Boral Capital LLC as the underwriter, relating to a firm commitment underwritten public offering of (i) 25,133,631 units (the “Units”) at a public offering price of $0.1118 per Unit, with each Unit consisting of one share of common stock, par value $0.0001 per share, of the Company (“Common Stock”), one Series A warrant to purchase one share of Common Stock at an exercise price of $0.1118 per share and one Series B warrant to purchase such number of shares of Common Stock as determined on the Reset Date as defined thereunder, at an exercise price of $0.0001 per shares, and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”) at a public offering price of $0.1117 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant (the “Pre-Funded Warrants”) exercisable for one share of Common Stock at an exercise price of $0.0001 per share, one Series A Warrant and one Series B Warrant. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

 

34

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis is intended as a review of significant factors affecting our financial condition and results of operations for the periods indicated. The discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and the other information set forth in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2024. In addition to historical information, the following Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ significantly from those anticipated in these forward-looking statements as a result of certain factors discussed herein and any other periodic reports filed and to be filed with the SEC. 

 

Reverse recapitalization 

 

Nature’s Miracle Holding Inc., which until March 11, 2024 was known as LBBB Merger Corp. (the “Company”, “we” or “us”) is a company incorporated on August 1, 2022 under Delaware law as a wholly owned subsidiary of the Lakeshore Acquisition II Corp., a Cayman Islands exempted company (“Lakeshore”). 

 

Lakeshore entered into the Merger Agreement with Nature’s Miracle Inc. (“Nature’s Miracle”) and shareholders of Nature’s Miracle and Lakeshore on September 9, 2022, and as amended on June 7, 2023. Pursuant to the terms of the Merger Agreement, the merger will be completed through a two-step process consisting of the reincorporation and the merger. Pursuant to the Merger Agreement, at the effective time of the merger, each share of Nature’s Miracle common stock issued and outstanding immediately prior to the effective time was cancelled and automatically converted into the right to receive the applicable pro rata portion of shares of our common stock, the aggregate value of which was equal to: (a) $230,000,000 minus (b) the estimated Closing Net Indebtedness (as defined in the Merger Agreement) (the “Merger Consideration”). 

 

On March 11, 2024, Lakeshore merged with and into the Company for the sole purpose of reincorporating Lakeshore into the State of Delaware (“Reincorporation”). Immediately after the Reincorporation, we consummated the merger resulting in the stockholders of Nature’s Miracle becoming 84.7% stockholders of our Company and our Company becoming the 100% stockholder of Nature’s Miracle. Immediately after giving effect to the merger, there were 26,306,764 issued and outstanding shares of our common stock. The consolidation of our Company and our subsidiaries have been accounted for as Lakeshore is the “acquired” company for financial reporting purposes at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements. All share and per share data has been retroactively restated to reflect our current capital structure.

 

Overview

 

We are a growing agriculture technology company providing products to indoor growers in a CEA (Controlled Environment Agriculture) setting in North America.

 

We focus on the greenhouse and cultivation industry and aim at providing integrated greenhouse solutions, including grow lights, dehumidifiers, coco and grow media for vertical farming and multiple growing system. These systems enable year-round cultivation of crops, avoids harsh environments with very cold or hot climate. Many states focused on farming are limited to grow crops are certain months such as Spring to Fall only, and or are too far from production states too have fresh produce year-round. There are cost advantages also as vertical farming systems produces a much higher yield per acre of land. In most cases, water consumption is much lower, up to 90%. Many indoor growers can locate closer to large population centers which can significantly reduce cost of trucking, and lead time whilst reducing carbon emissions as well. 

 

In February 2024 the Company started shipping a new product line of grow containers. These systems are indoor vertical farming units inside a traditional shipping container but equipped with temperature controls, multiple layers of growing space, L.E.D. lights, water controls and other systems. The Company has branded these “Growtainers” and “5 plus 1” representing five grow containers plus one container used as a control unit.

 

35

 

 

We operate mainly through two subsidiaries in California, Visiontech and Hydroman. Visiontech is known for the brand “eFinity” and provides high-efficiency and high-quality grow lights, grow media, fixtures and other related equipment; Hydroman supplie commercial greenhouse developers and owners with professional lighting technology and equipment.

 

In its first expansion plan, the Company has added additional products to our offering. These include organic and non-organic fertilizers, organic plant growth additives, and dehumidifiers. We have diverse suppliers including from countries such as India, Holland and Turkey. Additional equipment is being considered as well. These are value add components that will help growers increase yield, but more importantly reduce failures and dramatically improve growing environments such. The new products are a natural complement to its our base of LED grow lights.

 

The Company also seeks to enter the joint ventures in other industry verticals to utilize excess space available for vertical farming.

 

Trends and Expectations

 

The following factors have been important to our business, and we expect them to impact our results of operations and financial condition in future periods:

 

Product and Brand Development

 

We plan to increase investments in product and brand development. We actively evaluate and pursue acquisitions of product brand names and improvements on existing products. We continue to work with our suppliers in improving lighting products to be both of the highest quality and simultaneously cost effective for the customer. The Company invests in trips abroad to source and partner with manufacturing companies. We expect to develop additional manufacturing relationships and suppliers in Europe in the near future. 

 

The Company is also developing proprietary “all in one” automated and robotic indoor growing systems that are under design and testing phases.

 

The Company utilizes its vast network in the industry and recent publicity in listing on Nasdaq in acquiring leads for potential partnerships in sourcing, research and development of new product and business acquisitions.

  

Regulatory Environment

 

The importation of LED lighting and distribution of such equipment in the United States and Canada does not require strict government disclosures and technical inspections. The Company obtains local business permits to store in our main warehouses, obtain licenses to resell, and follows guidelines on packaging. Certain utility companies in the U.S. have programs that award rebates to heavy usage customers, some of which are in the indoor farming business. These customers are required to install LED lights with a minimum 50,000 hours life. There is also a performance requirement set by DesignLights Consortium, a non-profit energy improvement agency.

 

36

 

 

Sourcing 

 

The Company has long-term relationships with suppliers in Asia. Our top three suppliers of LED equipment are American Agricultural Innovation Technology Inc., Solislike-Tech Co., Ltd., Dongguan ZSC Lighting Co., Ltd. Each supplier provides us net 30 to net 90 day terms. The Company has also been approached by established lighting companies based in Japan and Germany. On grow feed, fertilizers and nutrients, our potential suppliers are based in Europe and some in Asia. Our grow container product was jointly developed and manufactured by a company based in Shenzhen, China.

 

On April 24, 2023, we entered into a strategic cooperation agreement with Sinoinnovo Technology (Guangdong) Co., Ltd. (“Sinoinnovo”), a company incorporated under the laws of China, pursuant to which Nature’s Mircle will source from Sinoinnovo its grow light systems for distribution in the U.S. and Europe. Both companies will also cooperate jointly to set up advanced manufacturing capabilities in China and the U.S.

 

RESULTS OF OPERATIONS

 

For the Three Months ended September 30, 2024 and 2023

 

The following table presents certain combined statement of operations information and presentation of that data as a percentage of change from year to year.

 

   For the Three Months Ended       Percentage 
   2024   2023   Change   Change 
Revenues   3,052,727    2,690,690    362,037    13.5%
Cost of revenues   2,824,614    2,531,922    292,692    11.6%
Gross profit   228,113    158,768    69,345    43.7%
Operating expenses   2,223,550    579,827    1,643,723    283.5%
Loss from operation   (1,995,437)   (421,059)   (1,574,378)   373.9%
Total other expense, net   (754,899)   (138,070)   (616,829)   446.8%
Loss before income taxes   (2,750,336)   (559,129)   (2,191,207)   391.9%
Total benefit of income taxes   -    (155,163)   155,163    (100.0)%
Net Loss   (2,750,336)   (403,966)   (2,346,370)   580.8%
Gross profit % of revenues   7.5%   5.9%          
Net Loss % of revenues   (90.1)%   (15.0)%          

 

Revenue

 

Revenue for the three months ended September 30, 2024 increased 13.5% to $3,052,727 as compared to $2,690,690 for the three months ended September 30, 2023. Revenue increased due to rising customer demand from existing customers and also new customers achieved via additional hiring of five sales-workers in first half of 2024 and the availability of new product lines that are new to 2024.

 

For the three months ended September 30, 2024 and 2023, we had 59 and 73 customers, respectively. Average revenue per customer for the three months ended September 30, 2024 and 2023 were approximately $51,741 and $36,859, respectively. Our revenue from top 5 customers for the three months ended September 30, 2024 was approximately $2.3 million compared to approximately $1.6 million for the three months ended September 30, 2023, representing an increase of 45.0%. The higher average sale and increased revenue from top 5 customer are reflective of higher industry demand.

 

In addition, our staff have been in constant communication with customers on their lighting and indoor farming needs and monitor their plans to replenish old equipment and related components as well us in building new facilities. We also hired a new director of sales in January 2024 plus in March of 2024 hired a new sales representative in northern California and another hired on the east coast.

 

Also, our principal business is in CEA industry which rapidly expanding due to growing consumer demand for low-environmental-impact food, local food systems, and improved accessibility to high-quality produce with shorter supply chains. In addition, our access to capital market will allow us to expend significant resources to compete, increase our product supply and develop new products and new market. Starting in 2023, the Company has two customers supplying LED lighting to growers that apply to rebate programs with utility companies. Utility companies are incentivizing volume users of electricity to convert to LED lighting by providing rebates. The rebate process can take time to verify and document by Utility companies resulting in payments of 60 to 120 days. The Company believes the credit quality of rebate payers more than offset the risk of long collection turnover of receivables. For the three months ended September 30, 2024 and 2023, the Company has sold via these programs with total sales to two customers of approximately $0.5 million and nil, respectively. 

 

37

 

 

Costs of Revenue

 

Costs of revenue for the three months ended September 30, 2024 increased 11.6% to $2,824,614 as compared to $2,531,922 for the three months ended September 30, 2023. Cost of revenue increased primarily due to the increase in revenue, which was in turn primarily driven by higher sales volume of our products due to higher customer demand.

 

Gross profit

 

Gross profit was $228,113 and $158,768 for the three months ended September 30, 2024 and 2023, respectively. The gross margin for the three months ended September 30, 2024 increase to 7.5% from 5.9% for the three months ended September 30, 2023. The increase was due to a combination of customers moving to premium grow lighting such as our own “Efinity” brand, more favorable purchasing conditions from Asian suppliers and the same fixed costs of warehouse rent and labor are spread over higher volume of sales.

 

Operating Expenses

 

Operating expenses for the three months ended September 30, 2024 increased 283.5% to $2,223,550 as compared to $579,827 for the three months ended September 30, 2023. The increase was mainly due to increased payroll and compensation expense of $353,003, which was attributed to increased compensation expenses provided to executives and key employees, increased professional fees of $469,503 and increased stock compensation expense of $848,075. The Company started its listing on Nasdaq in March 2024 and started paying director’s and officer’s insurance, higher legal costs related to listing and SEC filing activities, additional costs in public relations, increased stock compensation costs to employees, increased CPA review fees and outsourced providers.

 

Pursuant to a Letter Agreement entered on November 15, 2023, a total of 110,000 shares of our common stock will be issued upon closing of the merger in connection with certain transactions relating to our employment agreements, including: (i) 10,000 shares to Charles Jourdan Hausman in connection with his appointment as a board member with us and (ii) 100,000 shares to Darin Carpenter in connection with an employment agreement with us. The shares were valued at approximately $1.1 million and were expensed as general and administrative expenses in accordance with the service period.

 

Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 100,000, 50,000 and 50,000 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. The fair value of the shares to be issued was approximately $178,000 at $0.89 per share and were expensed as general and administrative expenses in accordance with the service period.

 

On April 2, 2024, we entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to us and the agreement has a term of six months. We will pay $14,000 cash per month and to issue MZHCI 150,000 shares of restricted common stock, 75,000 shares will be vested immediately upon signing the agreement and 75,000 shares will vest on October 1, 2024. The fair value of the shares to be issued was approximately $143,000 at $0.95 per share. The 150,000 shares were issued on May 7, 2024.

 

On August 1, 2024, we and Darin Carpenter entered into the mutual termination of employment agreement and intent to transition to project-based work (the “Agreement”), in which it was agreed that Mr. Carpenter shall resign from his position as Chief Operating Officer of us effective as of July 31, 2024. Pursuant to the Agreement, our Company and Mr. Carpenter agreed that Mr. Carpenter will provide services as a consultant to us on a per project basis as needed. In addition, we agreed to fully vest 100,013 shares of common stock that was issuable to Mr. Carpenter pursuant to the employment agreement dated as of September 17, 2023, by and between us and Mr. Carpenter. We also agreed to pay Mr. Carpenter the equivalent of one month of salary payable in September 2024.

 

Total stock compensation expenses amounted to $848,075 for the three months ended September 30, 2024.

 

Other Expenses

 

Other expenses primarily consist of net interest expense and other finance expense related to our loans. Other expenses for the three months ended September 30, 2024 was $754,899 as compared to other expense of $138,070 for the three months ended September 30, 2023. The increase was mainly due to the interest expenses increased by $605,421.

 

Interest expense for the three months ended of September 30, 2024 and 2023 was $738,468 and $133,047, respectively; increased as a result of multiple convertible and high interest loans in 2024.  

 

38

 

 

Income Tax Benefit

 

Our income tax benefit was amounted to $0 and $155,163 for the three months ended September 30, 2024 and 2023, respectively.

 

The effective tax rate for the three months ended September 30, 2024 and 2023 were 0 % and 27.8%, respectively. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets from our operating losses.

 

Net Loss 

 

Net loss for the three months ended September 30, 2024 was $2,750,336 as compared to net loss of $403,966 for the three months ended September 30, 2023, representing an increase of $2,346,370. The increase in net loss for the three months ended September 30, 2024 compared to the three months ended September 30, 2023 was primarily due to increased salaries and compensation expense and stock compensation expense after merger, higher level of legal and accounting costs related to the Nasdaq listing and SEC filings, higher public relations costs, new corporate offices and higher interest expense.

 

For the Nine Months ended September 30, 2024 and 2023

 

The following table presents certain combined statement of operations information and presentation of that data as a percentage of change from year to year.

 

   For the Nine Months Ended       Percentage 
   2024   2023   Change   Change 
Revenues   8,662,414    7,600,890    1,061,524    14.0%
Cost of revenues   7,669,764    7,044,591    625,173    8.9%
Gross profit   992,650    556,299    436,351    78.4%
Operating expenses   5,275,475    1,594,873    3,680,602    230.8%
Loss from operation   (4,282,825)   (1,038,574)   (3,244,251)   312.4%
Total other expense, net   (2,540,136)   (725,194)   (1,814,942)   250.3%
Loss before income taxes   (6,822,961)   (1,763,768)   (5,059,193)   286.8%
Total provision for (benefit of) income taxes   2,500    (385,853)   388,353    (100.6)%
Net Loss   (6,825,461)   (1,377,915)   (5,447,546)   395.3%
Gross profit % of revenues   11.5%   7.3%          
Net Loss % of revenues   (78.8)%   (18.1)%          

 

Revenue 

 

Revenue for the nine months ended September 30, 2024 increased 14.0% to $8,662,414 as compared to $7,600,890 for the nine months ended September 30, 2023. Revenue increased due to rising customer demand from existing customers, a larger salesforce in 2024 and an increase in products lines and services including our rebate program that was introduced in the second half of 2023.

 

For the nine months ended September 30, 2024 and 2023, we had 114 and 134 customers, respectively. Average revenue per customer for the nine months ended September 30, 2024 and 2023 were approximately $75,986 and $56,723, respectively. Our revenue from top 5 customers for the nine months ended September 30, 2024 was approximately $5.4 million compared to approximately $3.5 million for the nine months ended September 30, 2023, representing an increase of 54.0%. The higher average sale and increased revenue from top 5 customer are reflective of higher industry demand.

  

In addition, our staff have been in constant communication with customers on their lighting and indoor farming needs and monitor their plans to replenish old equipment and related components as well us in building new facilities. we also hired a new director of sales in January 2024 plus in March of 2024 hired a new sales representative in northern California and another hired on the east coast.

 

Also, our principal business is in CEA industry which rapidly expanding due to growing consumer demand for low-environmental-impact food, local food systems, and improved accessibility to high-quality produce with shorter supply chains. In addition, our access to capital market will allow us to expend significant resources to compete, increase our product supply and develop new products and new market. Starting in 2023, the Company has two customers supplying LED lighting to growers that apply to rebate programs with utility companies. Utility companies are incentivizing volume users of electricity to convert to LED lighting by providing rebates. The rebate process can take time to verify and document by Utility companies resulting in payments of 60 to 120 days. The Company believes the credit quality of rebate payers more than offset the risk of long collection turnover of receivables. For the nine months ended September 30, 2024 and 2023, the Company has sold via these programs with total sales to two customers of approximately $2.5 million and nil, respectively.

 

39

 

 

Costs of Revenue

 

Costs of revenue for the nine months ended September 30, 2024 increased 8.9% to $7,669,764 as compared to $7,044,591 for the nine months ended September 30, 2023. Cost of revenue increased primarily due to the increase in revenue, which was in turn primarily driven by higher sales volume of our products due to higher customer demand.

 

Gross Profit

 

Gross profit was $992,650 for the nine months ended September 30, 2024 and gross profit was $556,299 for nine months ended September 30, 2023. The gross margin for the nine months ended September 30, 2024 increase to 11.5% from 7.3% for the nine months ended September 30, 2023. The increase was due to better purchasing conditions with suppliers in Asia, higher margins achieved via rebate programs, and higher sales volume spread over fixed warehousing and labor costs. 

 

Operating Expenses

 

Operating expenses for the nine months ended September 30, 2024 increased 230.8% to $5,275,475 as compared to $1,594,873 for the nine months ended September 30, 2023. The increase was mainly due to increased payroll and compensation expense of $927,673, which was attributed to increased compensation expenses provided to executives and key employees, increased professional fees of $886,332, and increased stock compensation expense of $1,215,880. The Company started its listing on Nasdaq in March 2024 and started paying director’s and officer’s insurance, additional costs in public relations, increased stock compensation costs to employees and outsourced providers.

 

Pursuant to a Letter Agreement entered on November 15, 2023, a total of 110,000 shares of our common stock will be issued upon closing of the merger in connection with certain transactions relating to our employment agreements, including: (i) 10,000 shares to Charles Jourdan Hausman in connection with his appointment as a board member with us and (ii) 100,000 shares to Darin Carpenter in connection with an employment agreement with us. The shares were valued at approximately $1.1 million and were expensed as general and administrative expenses in accordance with the service period.

 

Pursuant to board resolution dated March 24, 2024, certain key employees were approved for stock incentives including George Yutuc (Chief Financial Officer), Kirk Collins (Director of Sales), and Amber Wang (Controller). Each can receive shares that vest over time of 100,000, 50,000 and 50,000 shares, respectively. Each of these employees have signed an employment agreement that reflects such shares and unique vesting schedules. The fair value of the shares to be issued was approximately $178,000 at $0.89 per share and were expensed as general and administrative expenses in accordance with the service period.

 

On April 2, 2024, we entered into an investor relations consulting agreement with MZHCI LLC (“MZHCI”) pursuant to which MZHCI will provide investor relations services to us and the agreement has a term of six months. We will pay $14,000 cash per month and to issue MZHCI 150,000 shares of restricted common stock, 75,000 shares will be vested immediately upon signing the agreement and 75,000 shares will vest on October 1, 2024. The fair value of the shares to be issued was approximately $143,000 at $0.95 per share. The 150,000 shares were issued on May 7, 2024.

 

On August 1, 2024, we and Darin Carpenter entered into the mutual termination of employment agreement and intent to transition to project-based work (the “Agreement”), in which it was agreed that Mr. Carpenter shall resign from his position as Chief Operating Officer of us effective as of July 31, 2024. Pursuant to the Agreement, we and Mr. Carpenter agreed that Mr. Carpenter will provide services as a consultant to us on a per project basis as needed. In addition, we agreed to fully vest 100,013 shares of common stock that was issuable to Mr. Carpenter pursuant to the Employment Agreement dated as of September 17, 2023, by and between us and Mr. Carpenter. We also agreed to pay Mr. Carpenter the equivalent of one month of salary payable in September 2024.

 

Total stock compensation expenses amounted to $1,215,880 for the nine months ended September 30, 2024.

  

Other Expenses

 

Other expenses primarily consist of net interest expense, non-cash finance expense, and other finance expense related to our loans. Other expenses for the nine months ended September 30, 2024 was $2,540,136 as compared to other expense of $725,194 for the nine months ended September 30, 2023. The increase was mainly due to the non-cash finance expense of $1.0 million and higher costs associated with a publicly-listed company.

 

Interest expense for the nine months ended of September 30, 2024 increased 209.8% to $1,527,443 as compared to $493,067 for the nine months ended of September 30, 2023, as a result of we obtained multiple convertible loans in 2024.

 

Pursuant to a Letter Agreement entered on November 15, 2023, a total of 100,000 shares of our common stock will be issued upon closing of the merger in connection with certain transactions relating to merger including: (i) 50,000 shares to Tie (James) Li and 50,000 shares to Zhiyi, Zhang (or 100,000 shares in the aggregate) in connection with their guarantees of the repayment of the Newtek Loan, which was loaned to a subsidiary of us with the principal amount of $3,700,000; The shares were valued at approximately $1.0 million and was expensed as non-cash finance expenses after consummation of the Merger. 

 

40

 

 

Income Tax Expense (Benefit)

 

Our income tax expense was amounted to $2,500 for the nine months ended September 30, 2024 and our income tax benefit was amounted to approximately $0.4 million for the nine months ended September 30, 2023.

 

The effective tax rate for the nine months ended September 30, 2024 and 2023 were 0% and 21.9%, respectively. The effective tax rate differs from the federal and state statutory tax rate of 21.0% primarily due to the valuation allowance on the deferred tax assets from our operating losses.

 

Net Loss 

 

Net loss for the nine months ended September 30, 2024 was $6,825,461 as compared to net loss of $1,377,915 for the nine months ended September 30, 2023, representing an increase of $5,447,546. The increase in net loss for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023 was primarily due to increased salaries and compensation expense, higher audit, legal, Nasdaq fees and other costs related to public companies, and stock compensation expense after merger.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Sources of Liquidity

 

In assessing liquidity, we monitor and analyze cash on-hand and operating expenditure commitments. Our liquidity needs are to meet working capital requirements and operating expense obligations. To date, we financed our operations primarily through debt financing from financial institution and related parties. As of September 30, 2024, we had approximately $40,114 in cash which primarily consists of bank deposits, which are unrestricted as to withdrawal and use. Our working capital deficit was approximately $11.7 million as of September 30, 2024.

 

On October 14, 2024, we entered into a securities purchase agreement with a certain investor pursuant to which we sold to the investor a convertible promissory note in the aggregate principal amount of $101,200 with an original issue discount of $13,200.  

 

On November 7, 2024, we entered into an underwriting agreement with D. Boral Capital LLC as the underwriter, relating to a firm commitment underwritten public offering of (i) 25,133,631 units (the “Units”) at a public offering price of $0.1118 per Unit, with each Unit consisting of one share of common stock, par value $0.0001 per share, of us (“Common Stock”), one Series A warrant to purchase one share of Common Stock at an exercise price of $0.1118 per share and one Series B warrant to purchase such number of shares of Common Stock as determined on the Reset Date as defined thereunder, at an exercise price of $0.0001 per shares, and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”) at a public offering price of $0.1117 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant (the “Pre-Funded Warrants”) exercisable for one share of Common Stock at an exercise price of $0.0001 per share, one Series A Warrant and one Series B Warrant. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

 

We have experienced recurring losses from operations and negative cash flows from operating activities since 2022. In addition, given our ongoing capital needs, our financial position is under pressure, and may potentially continue to have, an ongoing need to raise additional cash from outside sources to fund our expansion plan and related operations. Successful transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support our cost structure. In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued. If we are unable to realize our assets within the normal operating cycle of a twelve (12) month period, we may have to consider supplementing our available sources of funds through the following sources:

 

  financial support from our related parties and shareholders;

 

  other available sources of financing from banks and other financial institutions;

 

  equity financing through capital market

 

41

 

 

We can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to us, if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity shortfall, there would likely be a material adverse effect on us and would materially adversely affect our ability to continue as a going concern.

 

The unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty.

 

Cash Flows

 

The following tables set forth our selected unaudited condensed consolidated cash flow data for the periods indicated:

 

   For the Nine Months Ended September 30, 
   2024   2023 
   US$   US$ 
Net cash used in operating activities   (3,170,717)   (817,543)
Net cash used in investing activities   (39,803)   (257,087)
Net cash provided by financing activities   3,028,945    986,450 
Effect of exchange rate changes   (71)   876 
Net change in cash   (181,646)   (87,304)
Cash and cash equivalents, at the beginning of period   221,760    810,371 
Cash and cash equivalents, at the end of period   40,114    723,067 

 

Operating Activities

 

Net cash used in operating activities was approximately $3.2 million for the nine months ended September 30, 2024, which was mainly due to our net loss of approximately $4.0 million after adjustment of non cash items and increased accounts receivable of approximately $2.7 million due to increased revenue offset by cash inflow of approximately $1.3 million increased from accounts payable as we increased our purchase from vendors and approximately $1.7 million decreased in inventory as we used more on hand inventory.

 

Net cash used in operating activities was $817,543 for the nine months ended September 30, 2023, which was mainly due to our net loss of approximately $1.4 million and decrease of accounts payable of approximately $1.9 million as we payoff more vendors using on hand cash, offset by approximately $2.8 million decreased of inventory as we used more inventory on hand instead of making new purchases. 

 

Investing Activities

 

For the nine months ended September 30, 2024, net cash used in investing activities amount to approximately $40,000 which was primarily for loan to Lakeshore of $40,000 prior to the Merger, offset by net proceed from reverse recapitalization of $197.

 

For the nine months ended September 30, 2023, net cash used in investing activities amount to $257,087 which was primarily for loan to related parties of $390,000, offset by loan repayment from third parties of $132,913. 

 

Financing Activities

 

Net cash provided by financing activities was approximately $3.0 million for the nine months ended September 30, 2024. The main reason for the increase in net cash provided was primarily a result of net proceeds from short-term loan from third parties of $3.0 million, shares and warrants issued through July public offering of approximately $1.0 million, and convertible notes borrowing of approximately $0.8 million, offset by payments of deferred offering costs of approximately $0.3 million, repayments on long term loans which are mainly our car and mortgage loan of approximately $0.2 million, repayments on short-term loan from third parties of approximately $1.1 million, repayments on convertible notes of approximately $0.2 million.

 

Net cash provided by financing activities was approximately $1.0 million for the nine months ended September 30, 2023. The main reason for the increase in net cash provided was primarily a result of net proceeds from long-term loan borrowing from third parties of $3.3 million, and short-term loan borrowing from related parties of $0.8 million, offset by payments of deferred offering costs of $0.6 million, repayments on long term loans which are mainly our car and mortgage loan of $0.1 million, repayments on short-term loan from third parties of $1.8 million, and repayments on short-term loan from related parties of approximately $0.7 million. 

 

42

 

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S-K) that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States, or GAAP and pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition and results of operations will be affected. We base our estimates on experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies, which we discuss further below. While our significant accounting policies are more fully described in Note 3 to our unaudited condensed consolidated financial statements, we believe that the following accounting policies are critical to the process of making significant judgments and estimates in the preparation of our unaudited condensed consolidated financial statements.

 

Revenue recognition

 

We follow Accounting Standards Codification (“ASC”) 606 Revenue Recognition and recognizes revenue from product sales revenues, net of promotional discounts and return allowances, when the following revenue recognition criteria are met: a contract has been identified, separate performance obligations are identified, the transaction price is determined, the transaction price is allocated to separate performance obligations and revenue is recognized upon satisfying each performance obligation. 

 

We are a growing agriculture technology company providing CEA hardware products to growers in the controlled environment agriculture industry setting in North America.  Majority of our products were grow lights and related products for the indoor growing settings. Starting from first quarter of 2024, we also provide indoor grow containers to our customers.

 

Our contracts with customers where the amounts charged per product is fixed and determinable, the specific terms of the contracts were agreed on by us including payment terms which are typically 30 to 60 days for existing customers and prepaid for most new customers. In certain contracts involving customers that entered into rebate programs with utility companies for using LED lighting, payment term ranges from 60 to 120 days.

 

In determining the transaction price, we adjust consideration for the effects of the time value of money if the timing of payments provides us with a significant benefit of financing. We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customers and the transfer of the promised goods or services to the licensees will be one year or less. The risk of loss or damage upon shipment, therefore, revenue from product sales is recognized at a point in time when control of product transfer to customer and we have no further obligation to provide services related to such product. Return allowances which are immaterial based on historical experience.

 

We evaluate the criteria of ASC 606 — Revenue Recognition Principal-Agent Considerations in determining whether it is appropriate to record the gross amount of product sales and related costs, or the net amount earned as commissions.

 

We ship the products according to shipping terms on the purchase order or sales order. Once delivery is complete, we then send an invoice to the customer according to the quantity and price of shipment.

 

43

 

 

We evaluate the indicators of control in accordance with ASU 2016-08: 1) We are the most visible entity to customers and assumes fulfilment risk and risks related to the acceptability of products, including addressing customer inquiries directly and handling of product returns or refunds directly if any. For grow light products, we have our own brand for marketing. For indoor grow containers products, we are also involved in the design and technical specification of the products to meet requirement in the US market. 2) We assume inventory risk either through storing the products in our own warehouses; or for drop shipments directly from vendors, we take the title from vendors through inspection and acceptance and are responsible for product damage during shipment period prior to acceptance of our customers and are also responsible for product return if the customer is not satisfied with the products. 3) We determine the resale price of the products. 4) We are the party that direct the use of the inventory and can prevent the vendor from transferring the product to a customer or to redirect the products to a different customer, after evaluating the above scenario, we consider ourselves the principal of these arrangements and records revenue on a gross basis.

 

Payments received prior to the delivery of goods to customers or picked up by the customers are recorded as contract liabilities. 

 

We periodically provide incentive offers to our customers to encourage purchases. Such offers include current discount offers, such as percentage discounts off current purchases and other similar offers.

 

Current discount offers, when accepted by our customers, are treated as a reduction to the transaction price of the related transaction.

 

Sales discounts are recorded in the period in which the related sale is recognized. Sales return allowances are recorded upon recognizing the related sales.

  

Inventory

 

Inventory consists of finished goods ready for sale and is stated at the lower of cost or market. We value our inventory using the weighted average costing method. We include a part of cost of goods sold any freight incurred to ship the product from our vendors to warehouses. Outbound freight costs related to shipping costs to customers are considered period costs and reflected in cost of revenue. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.

 

If the estimated realizable value of the inventory is less than cost, we make provisions in order to reduce our carrying value to our estimated market value. We also review inventory for slow moving and obsolescence and records allowance for obsolescence.

   

Recently issued accounting pronouncements

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our unaudited condensed consolidated financial statements and related disclosures.

 

Except as mentioned above, we do not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on our unaudited condensed consolidated balance sheets, statements of income and comprehensive income and statements of cash flows.

 

44

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (“SEC”) rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

  

Evaluation of Disclosure Controls and Procedures

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2024. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of September 30, 2024, due solely to the material weakness in our internal control over financial reporting related to (i) a lack of effective risk assessment process; (ii) a lack of effective overall control environment; (iii) a lack of controls over monitoring; (iv) a lack of human resources within finance and accounting functions leading to lack of segregation of duties; (v) a lack of information technology control design and operating effectiveness; (vi) a lack of controls or ineffectively designed controls impacting financial reporting; (vii) an inadequate control over proper revenue recognition and purchase cutoff; and (viii) a lack of controls over income tax. Following the identification of the material weaknesses and control deficiencies, we plan to continue to take remedial measures including (i) hiring more qualified accounting personnel with relevant U.S. generally accepted accounting principles (“GAAP”) and SEC reporting experience and qualifications to strengthen the financial reporting function and to set up a financial and system control framework; (ii) implementing regular and continuous GAAP accounting and financial reporting training programs for our accounting and financial reporting personnel; (iii) engaging an external consulting firm to assist us with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control; and (iv) appointing independent directors, establishing an audit committee and strengthening corporate governance.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

  

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

45

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEDINGS

 

From time to time, claims are made against us in the ordinary course of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products or engaging in other activities. There were no reportable litigation events and there have been no material developments to litigation events previously disclosed in our SEC filings during the quarter ended September 30, 2024 except as described below. 

 

On August 29, 2024, Beverly Hills View, Inc.(“BHV”) brought a lawsuit against our subsidiary Visiontech, in Los Angeles Superior Court, alleging that the lighting products BHV received were not suitable for its cannabis growing operation and claiming damages of $2,500,000. The Company believes the complaint is without merit, and Visiontech filed an answer on October 30, 2024, along with a cross-complaint on November 4, 2024, asserting that BHV failed to pay for all the products it purchased.

 

On October 22, 2024, Growterra, LLC (“Growterra”) filed a complaint against the Company and the Company’s chief executive officer in the Court of Common Pleas, Hamilton County, Ohio, alleging that it purchased lighting products from the Company, under which the Company would provide Growterra software, IP, and design documentation related to hydroponic containers and identify Growterra as an additional insured on the Company’s product liability insurance. Growterra alleges the Company failed to perform these obligations. Growterra is alleging breach of contract, fraud, and misappropriation of trade secrets as well as related causes of action. Growterra does not state an amount of damages but is also seeking rescission. The Company has not yet answered.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this item. In any event, there have been no material changes in our risk factors as previously disclosed in the Registration Statement.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

(A) Unregistered Sales of Equity Securities

 

None.

 

(B) Use of Proceeds

 

Not applicable.

 

(C) Issuer Purchases of Equity Securities

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable. 

 

ITEM 5. OTHER INFORMATION

 

On October 24, 2024, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) (the “Delisting Notice”) notifying the Company that, as a result of the Company’s failure to regain compliance with Nasdaq’s continued listing requirements under Nasdaq’s Listing Rule 5450(b)(2)(A), requiring the market value of listed securities to be at least $50,000,000 for continued listing (the “MVLS Rule”), and Listing Rule 5450(b)(1)(C) requiring the market value of its publicly held shares to be at least $5,000,000 for continued listing (the “MVPHS Rule”) by the previously imposed deadline of October 23, 2024, Nasdaq has determined to delist the Company’s common stock from the Nasdaq Global Market.

 

On October 30, 2024, the Company submitted a request for a hearing to appeal this determination. The hearing request stays the suspension of the Company’s securities. At the hearing, which will be held on December 17, 2024, the Company will present a plan to regain compliance, and request an extension to demonstrate compliance with the Nasdaq continued listing requirements.

 

During the quarter ended September 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such term is defined in Item 408(a) of Regulation S-K. 

 

46

 

 

ITEM 6. EXHIBITS

 

EXHIBIT INDEX

 

Exhibit
Number
  Description
10.1   Form of Convertible Notes Investment Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on July 10, 2024).
10.2   Securities Purchase Agreement dated as of July 17, 2024, by and between Nature’s Miracle Holding Inc. and the investor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on July 19, 2024).
10.3   Convertible Promissory Note dated as of July 17, 2024, issued by Nature’s Miracle Holding Inc. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the SEC on July 19, 2024).
10.4   Common Stock Purchase Warrant dated as of July 17, 2024, issued by Nature’s Miracle Holding Inc. (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K of the Company filed with the SEC on July 19, 2024).
10.5   Underwriting Agreement dated as of July 25, 2024, by and between Nature’s Miracle Holding Inc. and EF Hutton LLC (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K of the Company filed with the SEC on July 30, 2024).
10.6   Mutual Termination of Employment Agreement and Intent to Transition to Project-Based Work dated as of August 1, 2024, by and between Nature’s Miracle Holding Inc. and Darin Carpenter (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on August 7, 2024).
10.7   Securities Purchase Agreement dated as of August 13, 2024, by and between Nature’s Miracle Holding Inc. and the investor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on August 16, 2024).
10.8   Convertible Promissory Note dated as of August 13, 2024, issued by Nature’s Miracle Holding Inc. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the SEC on August 16, 2024).
10.9   Securities Purchase Agreement dated as of September 18, 2024, by and between Nature’s Miracle Holding Inc. and the investor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on September 24, 2024).
10.10   Convertible Promissory Note dated as of September 18, 2024, issued by Nature’s Miracle Holding Inc. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the SEC on September 24, 2024).
10.11   Trade Payable Forgiveness Agreement dated as of September 24, 2024, by and between Nature’s Miracle Holding Inc., Visiontech Group, Inc., Uninet Global Inc., and Nature’s Miracle, Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on September 30, 2024).
31.1*   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**   Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**   Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Schema Document.
101.CAL*   Inline XBRL Calculation Linkbase Document.
101.DEF*   Inline XBRL Definition Linkbase Document.
101.LAB*   Inline XBRL Label Linkbase Document.
101.PRE*   Inline XBRL Presentation Linkbase Document.
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document filed as Exhibit 101).

 

* Filed herewith.

 

** Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

47

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  NATURE’S MIRACLE HOLDING INC.
   
Dated: November 14, 2024 /s/ Tie (James) Li
  Tie (James) Li
  Chief Executive Officer
(Principal Executive Officer)
   
Dated: November 14, 2024 /s/ George Yutuc
  George Yutuc
  Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

48

 

 

 

false --12-31 Q3 0001947861 0001947861 2024-01-01 2024-09-30 0001947861 nmhi:CommonStockParValue00001PerShareMember 2024-01-01 2024-09-30 0001947861 nmhi:WarrantsToPurchaseCommonStockAtAnExercisePriceOf1150PerShareMember 2024-01-01 2024-09-30 0001947861 2024-11-14 0001947861 2024-09-30 0001947861 2023-12-31 0001947861 us-gaap:RelatedPartyMember 2024-09-30 0001947861 us-gaap:RelatedPartyMember 2023-12-31 0001947861 2024-07-01 2024-09-30 0001947861 2023-07-01 2023-09-30 0001947861 2023-01-01 2023-09-30 0001947861 us-gaap:PreferredStockMember 2023-12-31 0001947861 us-gaap:CommonStockMember 2023-12-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001947861 us-gaap:RetainedEarningsMember 2023-12-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001947861 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001947861 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001947861 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001947861 2024-01-01 2024-03-31 0001947861 us-gaap:PreferredStockMember 2024-03-31 0001947861 us-gaap:CommonStockMember 2024-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001947861 us-gaap:RetainedEarningsMember 2024-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001947861 2024-03-31 0001947861 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001947861 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001947861 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001947861 2024-04-01 2024-06-30 0001947861 us-gaap:PreferredStockMember 2024-06-30 0001947861 us-gaap:CommonStockMember 2024-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001947861 us-gaap:RetainedEarningsMember 2024-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001947861 2024-06-30 0001947861 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001947861 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001947861 us-gaap:PreferredStockMember 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001947861 us-gaap:RetainedEarningsMember 2024-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001947861 us-gaap:PreferredStockMember 2022-12-31 0001947861 us-gaap:CommonStockMember 2022-12-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001947861 us-gaap:RetainedEarningsMember 2022-12-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001947861 2022-12-31 0001947861 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001947861 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001947861 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001947861 2023-01-01 2023-03-31 0001947861 us-gaap:PreferredStockMember 2023-03-31 0001947861 us-gaap:CommonStockMember 2023-03-31 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001947861 us-gaap:RetainedEarningsMember 2023-03-31 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001947861 2023-03-31 0001947861 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001947861 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001947861 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001947861 2023-04-01 2023-06-30 0001947861 us-gaap:PreferredStockMember 2023-06-30 0001947861 us-gaap:CommonStockMember 2023-06-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001947861 us-gaap:RetainedEarningsMember 2023-06-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001947861 2023-06-30 0001947861 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001947861 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001947861 us-gaap:PreferredStockMember 2023-09-30 0001947861 us-gaap:CommonStockMember 2023-09-30 0001947861 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001947861 us-gaap:RetainedEarningsMember 2023-09-30 0001947861 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001947861 2023-09-30 0001947861 nmhi:NaturesMiracleIncMember 2024-03-11 0001947861 nmhi:MergerAgreementMember 2024-03-11 0001947861 srt:DirectorMember nmhi:NaturesMiracleIncMember 2024-09-30 0001947861 nmhi:VisiontechGroupIncMember 2022-06-01 0001947861 nmhi:VisiontechMember 2022-06-01 0001947861 nmhi:NaturesMiracleIncMember 2024-09-30 0001947861 nmhi:HydromanMember 2022-06-01 0001947861 nmhi:HydromanMember us-gaap:CommonStockMember 2022-06-01 2022-06-01 0001947861 nmhi:PhotonTechnologyCanadaLtdMember 2022-08-18 0001947861 nmhi:PhotonTechnologyCanadaLtdMember 2022-08-18 2022-08-18 0001947861 2022-08-18 0001947861 nmhi:NaturesMiracleIncMember 2022-08-18 0001947861 nmhi:VisiontechGroupIncMember 2021-08-27 2021-08-27 0001947861 nmhi:VisiontechGroupIncMember 2021-08-27 0001947861 nmhi:VisiontechGroupIncMember 2022-01-10 0001947861 2022-01-10 0001947861 2022-01-10 2022-01-10 0001947861 nmhi:VisiontechGroupIncMember 2022-08-27 0001947861 us-gaap:SubsequentEventMember 2024-10-14 0001947861 nmhi:ConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember 2024-10-14 0001947861 nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 0001947861 nmhi:SeriesAWarrantMember nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:SeriesAWarrantMember nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 0001947861 nmhi:SeriesBWarrantMember nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:PreFundedWarrantMember nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 0001947861 nmhi:PreFundedWarrantMember nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:PreFundedWarrantMember us-gaap:SubsequentEventMember 2024-11-07 0001947861 us-gaap:CashMember 2024-01-01 2024-09-30 0001947861 us-gaap:MachineryAndEquipmentMember 2024-09-30 0001947861 us-gaap:ComputerEquipmentMember 2024-09-30 0001947861 us-gaap:TrucksMember 2024-09-30 0001947861 us-gaap:BuildingMember 2024-09-30 0001947861 nmhi:GrowLightMember 2024-07-01 2024-09-30 0001947861 nmhi:GrowLightMember 2023-07-01 2023-09-30 0001947861 nmhi:GrowLightMember 2024-01-01 2024-09-30 0001947861 nmhi:GrowLightMember 2023-01-01 2023-09-30 0001947861 nmhi:IndoorGrowContainersMember 2024-07-01 2024-09-30 0001947861 nmhi:IndoorGrowContainersMember 2023-07-01 2023-09-30 0001947861 nmhi:IndoorGrowContainersMember 2024-01-01 2024-09-30 0001947861 nmhi:IndoorGrowContainersMember 2023-01-01 2023-09-30 0001947861 2023-01-01 2023-12-31 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-09-30 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-07-01 2024-09-30 0001947861 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-01-01 2024-09-30 0001947861 nmhi:NMIMember 2024-03-11 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-03-11 0001947861 nmhi:PublicWarrantsMember 2024-09-30 0001947861 nmhi:PrivateWarrantsMember 2024-09-30 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-01-01 2024-09-30 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-01-01 2024-09-30 0001947861 nmhi:NMIMember 2024-01-01 2024-09-30 0001947861 nmhi:LakeshoresSharesMember 2024-09-30 0001947861 nmhi:NMIMember 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:LakeshoresSharesMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:SharesIssuedToPrivateRightsMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:ConversionOfLakeshoresPublicSharesAndRightsMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:SharesIssuedToServiceProvidersMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:BonusSharesIssuedToInvestorsMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember nmhi:ConversionOfNMIsSharesMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001947861 2024-03-11 2024-03-11 0001947861 us-gaap:RelatedPartyMember 2024-09-30 0001947861 us-gaap:RelatedPartyMember 2023-12-31 0001947861 nmhi:VisiontechAndCGGPLLCCGGPMember 2022-09-30 0001947861 nmhi:VisiontechAndCGGPLLCCGGPMember 2023-07-01 2023-09-30 0001947861 nmhi:VisiontechAndCGGPLLCCGGPMember 2023-01-01 2023-09-30 0001947861 nmhi:VisiontechAndNewCoVisionLLCNewCoMember 2022-09-30 0001947861 nmhi:VisiontechAndNewCoVisionLLCNewCoMember 2023-07-01 2023-09-30 0001947861 nmhi:VisiontechAndNewCoVisionLLCNewCoMember 2023-01-01 2023-09-30 0001947861 nmhi:IluminarLightingLLCMember 2023-04-11 2023-04-11 0001947861 us-gaap:TransportationEquipmentMember 2024-09-30 0001947861 us-gaap:TransportationEquipmentMember 2023-12-31 0001947861 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001947861 us-gaap:BuildingMember 2023-12-31 0001947861 us-gaap:LandMember 2024-09-30 0001947861 us-gaap:LandMember 2023-12-31 0001947861 nmhi:FactorHMember 2023-10-23 2023-10-23 0001947861 nmhi:FactorHMember 2023-10-23 0001947861 nmhi:VisiontechAndHydromanMember 2024-07-01 2024-09-30 0001947861 nmhi:VisiontechAndHydromanMember 2024-01-01 2024-09-30 0001947861 2024-05-02 2024-05-02 0001947861 nmhi:MerchantsMember 2024-01-01 2024-09-30 0001947861 2023-10-23 0001947861 nmhi:FactorHMember 2024-07-01 2024-09-30 0001947861 nmhi:FactorHMember 2024-01-01 2024-09-30 0001947861 2024-08-29 2024-08-29 0001947861 nmhi:MerchantsMember 2024-08-29 2024-08-29 0001947861 nmhi:FactorIMember 2024-07-01 2024-09-30 0001947861 nmhi:FactorIMember 2024-01-01 2024-09-30 0001947861 2024-09-27 2024-09-27 0001947861 nmhi:MerchantsMember 2024-09-27 0001947861 nmhi:FactorJMember 2024-07-01 2024-09-30 0001947861 nmhi:FactorJMember 2024-01-01 2024-09-30 0001947861 2024-09-01 2024-09-30 0001947861 nmhi:FactorKMember 2024-09-01 2024-09-30 0001947861 nmhi:FactorKMember 2024-07-01 2024-09-30 0001947861 nmhi:FactorKMember 2024-01-01 2024-09-30 0001947861 nmhi:LoanAgreementMember 2023-10-30 0001947861 nmhi:IndependentThirdPartyMember 2023-10-30 2023-10-30 0001947861 nmhi:IndependentThirdPartyMember 2024-01-01 2024-09-30 0001947861 nmhi:IndependentThirdPartyMember 2023-01-01 2023-12-31 0001947861 nmhi:NaturesMiraclesMember 2024-03-07 0001947861 nmhi:PengZhangMember 2024-03-07 0001947861 nmhi:SevenPromissoryNotesMember 2024-09-30 0001947861 nmhi:SevenPromissoryNotesMember 2024-01-01 2024-09-30 0001947861 nmhi:NaturesMiraclesMember 2023-07-11 0001947861 2023-07-11 0001947861 nmhi:RedoneAndDeyinChenBillMember 2024-03-11 0001947861 nmhi:DeyinChenBillMember 2024-03-11 0001947861 nmhi:FirstPaymentMember 2024-03-11 2024-03-11 0001947861 nmhi:SecondPaymentMember 2024-03-11 2024-03-11 0001947861 nmhi:FinalPaymentMember 2024-03-11 2024-03-11 0001947861 nmhi:RedoneAndDeyinChenBillMember 2024-07-01 2024-09-30 0001947861 nmhi:RedoneAndDeyinChenBillMember 2024-01-01 2024-09-30 0001947861 2024-06-06 0001947861 nmhi:AdministrativeAgentFeeMember 2024-06-06 2024-06-06 0001947861 2024-06-06 2024-06-06 0001947861 nmhi:MerchantsMember 2024-06-06 0001947861 srt:MaximumMember nmhi:AgileCapitalFundingLLCMember 2024-07-01 2024-09-30 0001947861 srt:MaximumMember nmhi:AgileCapitalFundingLLCMember 2024-01-01 2024-09-30 0001947861 2024-09-25 0001947861 2024-09-25 2024-09-25 0001947861 nmhi:MerchantsMember 2024-09-25 0001947861 srt:MinimumMember nmhi:AgileCapitalFundingLLCMember 2024-07-01 2024-09-30 0001947861 srt:MinimumMember nmhi:AgileCapitalFundingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:RedoneAndDeyinChenMember 2022-08-31 2022-08-31 0001947861 nmhi:FactorAMember 2022-08-31 2022-08-31 0001947861 nmhi:MerchantsMember 2022-08-31 0001947861 nmhi:FactorAMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorAMember 2023-01-01 2023-09-30 0001947861 nmhi:FactorBMember 2022-09-01 2022-09-01 0001947861 nmhi:FactorBMember 2022-09-01 0001947861 nmhi:FactorBMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorBMember 2023-01-01 2023-09-30 0001947861 nmhi:FactorCMember 2022-10-31 2022-10-31 0001947861 nmhi:VisiontechMember 2022-10-31 2022-10-31 0001947861 nmhi:FactorCMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorCMember 2023-01-01 2023-09-30 0001947861 nmhi:CapitalManagementInstitutionDMember 2022-10-31 2022-10-31 0001947861 nmhi:CapitalManagementInstitutionDMember 2022-10-31 0001947861 nmhi:PurchaseAgreementMember 2023-07-01 2023-09-30 0001947861 nmhi:PurchaseAgreementMember 2023-01-01 2023-09-30 0001947861 nmhi:FactorEMember 2022-11-02 2022-11-02 0001947861 nmhi:FactorEMember 2022-11-02 0001947861 nmhi:FactorEMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorEMember 2023-01-01 2023-09-30 0001947861 nmhi:FactorFMember 2022-11-18 2022-11-18 0001947861 nmhi:FactorFMember 2022-11-18 0001947861 nmhi:FactorFMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorFMember 2023-01-01 2023-09-30 0001947861 nmhi:FactorGMember 2022-11-18 2022-11-18 0001947861 nmhi:FactorGMember 2022-11-18 0001947861 nmhi:FactorGMember 2023-07-01 2023-09-30 0001947861 nmhi:FactorGMember 2023-01-01 2023-09-30 0001947861 2022-09-21 0001947861 2022-09-21 2022-09-21 0001947861 nmhi:WebBankMember 2023-07-01 2023-09-30 0001947861 nmhi:WebBankMember 2023-01-01 2023-09-30 0001947861 2022-09-18 0001947861 nmhi:RedoneAndDeyinChenBillMember 2022-09-18 2022-09-18 0001947861 nmhi:HydromanAndClassicPlanPremiumFinancingIncMember 2023-07-01 2023-09-30 0001947861 nmhi:HydromanAndClassicPlanPremiumFinancingIncMember 2023-01-01 2023-09-30 0001947861 2023-02-13 0001947861 nmhi:RedoneAndDeyinChenBillMember 2023-02-13 2023-02-13 0001947861 nmhi:HydromanAndFirstInsuranceFundingMember 2023-07-01 2023-09-30 0001947861 nmhi:HydromanAndFirstInsuranceFundingMember 2023-01-01 2023-09-30 0001947861 us-gaap:VehiclesMember 2021-02-27 2021-02-27 0001947861 us-gaap:VehiclesMember 2021-02-27 0001947861 nmhi:LongTermDebtsAutoLoansMember 2024-01-01 2024-09-30 0001947861 nmhi:SecondVehicleMember 2021-06-08 2021-06-08 0001947861 nmhi:SecondVehicleMember 2021-06-08 0001947861 nmhi:ThirdVehicleMember 2022-09-28 2022-09-28 0001947861 nmhi:ThirdVehicleMember 2022-09-28 0001947861 nmhi:AutoLoansMember 2024-07-01 2024-09-30 0001947861 nmhi:AutoLoansMember 2024-01-01 2024-09-30 0001947861 nmhi:AutoLoansMember 2023-07-01 2023-09-30 0001947861 nmhi:AutoLoansMember 2023-01-01 2023-09-30 0001947861 us-gaap:BuildingMember 2024-01-01 2024-09-30 0001947861 us-gaap:BuildingMember 2023-01-01 2023-12-31 0001947861 nmhi:LongTermDebtsAutoLoansMember 2024-07-01 2024-09-30 0001947861 nmhi:BuildingLoanMember 2023-07-01 2023-09-30 0001947861 nmhi:BuildingLoanMember 2023-01-01 2023-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2023-01-01 2023-12-31 0001947861 nmhi:SecuredBusinessLoanMember 2023-06-14 0001947861 nmhi:BusinessLoanMember 2024-01-01 2024-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2024-07-01 2024-09-30 0001947861 nmhi:SecuredBusinessLoanMember 2024-01-01 2024-09-30 0001947861 srt:MaximumMember nmhi:BusinessLoanMember 2023-07-01 2023-09-30 0001947861 srt:MinimumMember nmhi:BusinessLoanMember 2023-01-01 2023-09-30 0001947861 nmhi:AutoLoansMember 2024-09-30 0001947861 nmhi:BuildingLoanMember 2024-09-30 0001947861 nmhi:BusinessLoanMember 2024-09-30 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvesteeMember 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-07-03 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember us-gaap:InvestorMember 2024-07-03 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-07-01 2024-09-30 0001947861 nmhi:ConvertibleNoteAgreementsMember 2024-01-01 2024-09-30 0001947861 2024-07-17 0001947861 2024-07-17 2024-07-17 0001947861 us-gaap:WarrantMember 2024-07-17 0001947861 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2024-07-17 0001947861 us-gaap:InvestorMember 2024-07-19 2024-07-19 0001947861 2024-07-19 2024-07-19 0001947861 nmhi:ConvertibleNotesMember 2024-07-19 2024-07-19 0001947861 nmhi:PromissoryNoteMember 2024-08-13 0001947861 nmhi:PromissoryNoteMember 2024-08-13 2024-08-13 0001947861 nmhi:DiagonalLendingLLCMember 2024-08-13 2024-08-13 0001947861 2024-08-13 2024-08-13 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-07-01 2024-09-30 0001947861 nmhi:PromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:ConvertiblePromissoryNoteMember nmhi:DiagonalLendingLLCMember 2024-09-18 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-09-18 2024-09-18 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-07-01 2024-09-30 0001947861 nmhi:ConvertiblePromissoryNoteMember 2024-01-01 2024-09-30 0001947861 nmhi:ConvertibleNotesMember 2024-07-01 2024-09-30 0001947861 nmhi:ConvertibleNotesMember 2024-01-01 2024-09-30 0001947861 nmhi:UniNetGlobalIncMember 2024-07-29 2024-07-29 0001947861 2023-01-01 2023-04-30 0001947861 nmhi:MegaphotonMember 2023-01-01 2023-04-30 0001947861 nmhi:CustomersMember nmhi:IluminarLightingLLCMember 2023-04-11 0001947861 2023-04-11 0001947861 2023-04-11 2023-04-11 0001947861 nmhi:IluminarLightingLLCMember 2024-07-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember 2024-01-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember 2023-07-01 2023-09-30 0001947861 nmhi:IluminarLightingLLCMember 2023-01-01 2023-09-30 0001947861 2022-01-01 2022-12-31 0001947861 nmhi:YangWeiMember 2021-01-01 2021-12-31 0001947861 nmhi:YangWeiMember 2024-01-01 2024-09-30 0001947861 nmhi:YangWeiMember 2023-01-01 2023-12-31 0001947861 nmhi:ZhiyiZhangMember 2022-01-01 2022-12-31 0001947861 nmhi:ZhiyiZhangMember 2023-05-19 2023-05-19 0001947861 nmhi:ZhiyiZhangMember 2023-09-04 2023-09-04 0001947861 nmhi:ZhiyiZhangMember 2024-07-01 2024-07-01 0001947861 nmhi:ZhiyiZhangMember 2023-10-11 2023-10-11 0001947861 nmhi:ZhiyiZhangMember 2024-01-01 2024-09-30 0001947861 nmhi:ZhiyiZhangMember 2023-01-01 2023-12-31 0001947861 nmhi:JamesLiMember 2024-09-01 2024-09-30 0001947861 nmhi:JamesLiMember 2024-09-30 2024-09-30 0001947861 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001947861 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001947861 nmhi:PromissoryNoteMember 2023-06-08 0001947861 nmhi:OnePromissoryNoteMember 2023-07-07 0001947861 nmhi:TwoPromissoryNoteMember 2023-08-10 0001947861 nmhi:ThreePromissoryNoteMember 2023-09-11 0001947861 nmhi:FourPromissoryNotesMember 2023-10-11 0001947861 nmhi:FivePromissoryNoteMember 2023-11-09 0001947861 nmhi:OnePromissoryNoteMember 2023-12-07 0001947861 nmhi:TwoPromissoryNoteMember 2024-01-08 0001947861 nmhi:ThreePromissoryNoteMember 2024-02-06 0001947861 nmhi:ZhiyiZhangMember 2022-11-29 0001947861 nmhi:ZhiyiZhangMember 2024-09-30 0001947861 nmhi:ZhiyiZhangMember 2023-12-31 0001947861 nmhi:TieLiMember 2022-12-31 0001947861 nmhi:TieLiMember 2023-06-16 2023-06-16 0001947861 nmhi:TieLiMember 2024-02-15 2024-02-15 0001947861 nmhi:TieLiMember 2024-09-30 0001947861 nmhi:TieLiMember 2023-12-31 0001947861 nmhi:TieJamesLiMember 2023-07-11 0001947861 nmhi:TieJamesLiMember 2024-09-30 0001947861 nmhi:NaturesMiracleHoldingIncMember 2023-01-17 0001947861 nmhi:NaturesMiracleHoldingIncMember 2024-09-30 0001947861 nmhi:NaturesMiracleHoldingIncMember 2023-12-31 0001947861 nmhi:NMCaymanMember 2023-01-17 0001947861 nmhi:PromissoryNoteMember 2023-04-01 0001947861 us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001947861 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001947861 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001947861 nmhi:LoanToDoudakianVartoLevonMember 2024-09-30 0001947861 nmhi:LoanToDoudakianVartoLevonMember 2023-12-31 0001947861 us-gaap:PreferredStockMember 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-09-30 0001947861 nmhi:LetterAgreementMember 2023-11-15 0001947861 nmhi:IncentivePlan2024Member 2024-01-01 2024-09-30 0001947861 nmhi:CharlesHausmanMember 2023-08-23 0001947861 nmhi:JamesLiMember 2023-08-23 0001947861 nmhi:ZhiyiZhangMember 2023-08-23 0001947861 nmhi:MrCarpenterMember 2024-09-30 0001947861 2023-09-17 2023-09-17 0001947861 nmhi:GeorgeYutucMember 2024-01-01 2024-09-30 0001947861 nmhi:KirkCollinsMember 2024-01-01 2024-09-30 0001947861 nmhi:AmberWangMember 2024-01-01 2024-09-30 0001947861 2024-04-02 2024-04-02 0001947861 nmhi:MZHCILLCMember 2024-04-02 2024-04-02 0001947861 us-gaap:SubsequentEventMember 2024-10-01 2024-10-01 0001947861 2024-04-02 0001947861 nmhi:MZHCILLCMember 2024-05-07 2024-05-07 0001947861 2024-07-19 0001947861 2024-07-29 2024-07-29 0001947861 us-gaap:IPOMember 2024-07-29 0001947861 us-gaap:IPOMember 2024-07-29 2024-07-29 0001947861 us-gaap:CommonStockMember us-gaap:IPOMember 2024-07-29 0001947861 us-gaap:WarrantMember 2024-09-30 0001947861 nmhi:BusinessCombinationMember 2024-09-30 0001947861 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-07-17 0001947861 nmhi:SeriesAWarrantMember 2024-07-29 0001947861 nmhi:SeriesAWarrantMember us-gaap:CommonStockMember 2024-07-29 0001947861 nmhi:SeriesAWarrantMember 2024-09-30 0001947861 nmhi:SeriesAWarrantMember 2024-01-01 2024-09-30 0001947861 us-gaap:CommonStockMember 2024-03-11 0001947861 us-gaap:WarrantMember 2023-12-31 0001947861 us-gaap:WarrantMember 2023-12-31 2023-12-31 0001947861 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001947861 us-gaap:WarrantMember 2024-03-31 0001947861 us-gaap:WarrantMember 2024-04-01 2024-06-30 0001947861 us-gaap:WarrantMember 2024-06-30 0001947861 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerHMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerHMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerIMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerIMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:IluminarLightingLLCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerJMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001947861 nmhi:CustomerJMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2024-01-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2024-01-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorBMember 2024-01-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorEMember 2024-01-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-07-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-01-01 2024-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorFMember 2024-01-01 2024-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2023-07-01 2023-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2023-01-01 2023-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorAMember 2023-01-01 2023-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorCMember 2023-07-01 2023-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorCMember 2023-01-01 2023-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:VendorCMember 2023-01-01 2023-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2023-07-01 2023-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2023-01-01 2023-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:MegaphotonMember 2023-01-01 2023-12-31 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:UninetGlobalIncMember 2023-07-01 2023-09-30 0001947861 nmhi:PurchaseMember us-gaap:SupplierConcentrationRiskMember nmhi:UninetGlobalIncMember 2023-01-01 2023-09-30 0001947861 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember nmhi:UninetGlobalIncMember 2023-01-01 2023-12-31 0001947861 us-gaap:LeaseAgreementsMember 2024-09-30 0001947861 us-gaap:LeaseAgreementsMember 2023-12-31 0001947861 stpr:TX 2024-09-30 0001947861 stpr:TX 2021-03-01 2022-02-28 0001947861 stpr:TX 2022-03-01 2023-02-28 0001947861 stpr:TX 2023-03-01 2024-02-29 0001947861 stpr:PA 2021-04-14 0001947861 stpr:PA 2021-06-01 2022-05-31 0001947861 stpr:PA 2022-06-01 2023-05-31 0001947861 stpr:PA 2023-06-01 2024-05-31 0001947861 stpr:CA 2024-09-30 0001947861 stpr:CA 2021-05-15 2021-05-15 0001947861 nmhi:McLovinsPetFoodIncMember 2024-01-01 2024-09-30 0001947861 nmhi:McLovinsPetFoodIncMember 2022-06-16 2023-06-15 0001947861 2023-06-16 2024-06-15 0001947861 srt:ScenarioForecastMember 2024-06-16 2025-06-15 0001947861 us-gaap:LeaseAgreementsMember 2022-05-16 2023-05-15 0001947861 2023-05-16 2024-05-15 0001947861 srt:ScenarioForecastMember us-gaap:LeaseAgreementsMember nmhi:McLovinsPetFoodIncMember 2024-05-16 2025-05-15 0001947861 nmhi:PhotonTechnologyLtdMember 2022-09-01 0001947861 nmhi:NaturesMiracleMember 2022-09-21 0001947861 2023-05-28 0001947861 srt:ScenarioForecastMember 2024-05-01 2025-04-30 0001947861 srt:ScenarioForecastMember 2025-05-01 2026-04-30 0001947861 srt:ScenarioForecastMember 2026-05-01 2027-04-30 0001947861 nmhi:VisiontechGroupIncMember 2024-09-30 0001947861 2023-08-22 0001947861 us-gaap:CommonStockMember 2024-04-26 0001947861 2024-04-26 0001947861 2024-05-23 0001947861 nmhi:PromissoryNoteMember us-gaap:SubsequentEventMember 2024-10-14 0001947861 us-gaap:SubsequentEventMember 2024-10-14 2024-10-14 0001947861 nmhi:UnpaidInterestMember us-gaap:SubsequentEventMember 2024-10-14 0001947861 nmhi:MVLSRuleMember us-gaap:SubsequentEventMember 2024-10-24 0001947861 nmhi:MVPHSRuleMember us-gaap:SubsequentEventMember 2024-10-24 0001947861 nmhi:WaterfordLLCMember us-gaap:SubsequentEventMember 2024-10-25 2024-10-25 0001947861 nmhi:WaterfordLLCMember us-gaap:SubsequentEventMember 2024-10-25 0001947861 nmhi:WaterfordLLCMember us-gaap:SubsequentEventMember 2024-10-25 0001947861 us-gaap:SubsequentEventMember 2024-10-25 0001947861 nmhi:DBoralCapitalLLCMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:DBoralCapitalLLCMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-11-07 2024-11-07 0001947861 nmhi:PreFundedWarrantMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:SeriesAWarrantMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 0001947861 nmhi:SeriesBWarrantMember us-gaap:SubsequentEventMember 2024-11-07 2024-11-07 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:CAD